Risteys ·

OMOP concept ID	Test name	Measurement unit (harmonized unit)	N people	N records	Missing measurement value	Harmonized value distribution
3010503	b-cd19	10E9/l (e6/l)	1388	2858	0.59%
3010503	b-cd19	E6/l (e6/l)	1257	3891	0.00%
3010503	b-cd19	— (—)	150	172	100.00%	Distribution not available
3010503	b-cd19	10E9/l____ (e6/l)	8	10	0.00%	Distribution not available

LabWAS

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

Abnormal findings on diagnostic imaging and in function studies, without diagnosis

751

1381

4.80

313.46

2.6

2.5

373.04

310.40

e6/l

0.18

730

1338

845

1006

4.96

312.76

2.8

2.4

300.60

150.78

e6/l

1.02

823

977

COPD/asthma/ILD related pneumonia or pneumonia derived septicaemia

845

1006

4.96

312.76

2.8

2.4

300.60

150.78

e6/l

1.02

823

977

Pneumonias (Asthma/COPD co-morbidities)

970

1532

4.18

308.91

2.7

2.5

356.70

179.01

e6/l

1.25

947

1494

L04AX Other immunosuppressants

673

1367

5.00

308.60

2.2

2.8

146.59

360.14

e6/l

1.65

654

1330

L04AA Selective immunosuppressants

418

531

8.15

307.89

3.0

2.6

122.03

257.88

e6/l

0.95

410

514

Other bacterial diseases

961

1405

4.58

307.65

2.8

2.5

212.49

355.50

e6/l

0.88

933

1370

Bacterial infection, other or unspecified

734

928

6.81

307.65

2.9

2.4

146.57

416.27

e6/l

1.53

709

898

Agranulocytosis

323

239

14.41

307.65

3.2

2.2

100.10

149.47

e6/l

1.31

317

228

ILD medications: prednisolone, methylprednisolone, prednisone

1109

959

6.51

307.65

2.5

165.53

495.09

e6/l

1.99

1076

935

First line medication for Crohn's disease

1077

979

5.99

307.65

2.7

217.76

389.51

e6/l

0.84

1047

959

Non-Hodgkin lymphoma, all, including Hilmo

558

163

37.68

307.65

2.9

2.1

224.10

131.36

e6/l

0.80

550

155

Secondary uncertain malignant neoplasm

364

169

22.79

307.65

2.8

2.1

285.28

135.19

e6/l

0.50

356

161

Secondary and unspecified malignant neoplasm of lymph nodes

331

112

32.36

307.65

2.7

2.0

301.68

141.04

e6/l

0.49

325

105

Autoimmune diseases related-to ILD

872

1644

4.48

307.65

2.8

2.5

155.70

392.42

e6/l

2.25

850

1599

Second line medication for Crohn's disease

698

1401

5.06

307.65

2.2

2.8

146.33

355.27

e6/l

1.67

678

1365

Secondary and unspecified malignant neoplasm of lymph nodes, including Hilmo

367

219

17.61

307.65

2.7

2.2

282.65

184.30

e6/l

0.28

359

211

Liquid cancers

907

406

22.42

307.65

3.2

2.2

592.10

159.89

e6/l

2.40

886

387

Fever of other and unknown origin

803

925

7.67

307.65

2.9

2.4

316.79

318.20

e6/l

0.00

787

898

Primary_lymphoid and hematopoietic malignant neoplasms

858

407

22.70

307.65

3.2

2.2

615.83

156.01

e6/l

2.44

841

389

Non-follicular lymphoma

424

178

26.54

307.65

2.8

2.2

197.83

158.50

e6/l

0.24

417

168

ILD medications: immunosuppressive drugs

987

897

10.19

307.65

2.8

2.5

144.25

488.04

e6/l

1.98

965

874

Liquid cancers, including Hilmo

950

478

18.39

307.65

3.2

2.2

571.81

156.72

e6/l

2.43

926

458

ILD medications

1215

980

6.77

307.65

2.8

2.5

145.11

488.34

e6/l

2.26

1183

956

Inflammatory bowel disease treatment related agents

1112

1318

4.73

307.65

2.3

2.9

171.32

386.91

e6/l

1.65

1075

1293

Oral corticosteroids

1111

1276

5.17

307.65

2.3

2.9

162.29

389.45

e6/l

1.72

1075

1251

Bacterial infection, other or unspecified, including avohilmo

758

992

6.38

307.65

2.9

2.4

144.94

402.50

e6/l

1.59

733

962

Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism

1189

1346

6.05

307.65

2.7

2.5

408.72

213.87

e6/l

1.09

1161

1308

Other diseases of blood and blood-forming organs, wide

489

485

10.53

307.65

3.1

2.4

435.56

181.91

e6/l

0.76

475

466

Autoimmune diseases excluding thyroid diseases

981

1242

4.33

301.67

2.6

282.11

356.11

e6/l

0.27

962

1208

Autoimmune diseases excluding thyroid diseases, strict definition

958

1211

4.35

296.86

2.6

286.27

361.39

e6/l

0.26

939

1179

Pneumonia, organism unspecified

884

1431

4.28

295.62

2.7

2.5

356.48

181.13

e6/l

1.12

861

1394

All pneumoniae

958

1571

4.00

288.40

2.7

2.5

358.94

177.80

e6/l

1.27

935

1533

Influenza and pneumonia

974

1524

3.98

285.75

2.8

2.5

338.95

180.45

e6/l

1.08

950

1487

Abnormal findings on diagnostic imaging of lung

578

1045

5.33

279.69

2.5

447.51

349.41

e6/l

0.22

560

1009

Other bacterial diseases, including avohilmo

924

1452

4.01

274.92

2.9

2.5

216.86

351.86

e6/l

0.83

900

1418

Certain disorders involving the immune mechanism

357

445

8.32

267.32

2.7

2.6

501.23

262.72

e6/l

0.48

350

429

Pneumonia (excl. viral and due to other infectious organisms not elsewhere classified)

909

1603

3.81

259.21

2.7

2.6

379.61

172.06

e6/l

1.45

885

1565

Septicaemia

448

742

5.59

225.48

2.9

2.3

228.90

469.23

e6/l

0.78

432

715

Aplastic and other anaemias

520

1002

4.82

222.12

2.8

2.3

98.42

447.18

e6/l

2.37

506

963

Other septicaemia, including avohilmo

419

689

5.80

221.55

3.0

2.3

191.26

494.20

e6/l

1.00

402

664

Malignant neoplasm

693

965

4.25

215.94

3.2

2.4

314.34

155.85

e6/l

1.28

679

935

Other septicaemia

408

677

5.77

215.14

3.0

2.3

193.73

489.94

e6/l

0.94

392

652

Malignant neoplasm

691

966

4.23

214.32

3.2

2.4

314.91

156.13

e6/l

1.27

677

936

Other and unspecified anaemias

477

923

4.93

210.81

2.9

2.3

87.34

477.55

e6/l

2.49

464

885

Other anaemias

479

928

4.91

210.44

2.9

2.3

87.88

475.16

e6/l

2.48

466

890

ILD, hospital admission 2, with pulmonary infections

188

133

14.71

208.09

2.3

2.2

103.93

91.38

e6/l

0.44

183

127

Malignant neoplasm, including Hilmo

684

984

4.09

202.97

3.2

2.4

313.80

153.99

e6/l

1.27

671

955

ILD medications: azathioprine

208

181

11.80

202.70

2.2

2.3

197.11

499.81

e6/l

0.58

200

174

Malignant neoplasm, wide definition

681

989

4.04

199.53

3.2

2.4

314.52

155.19

e6/l

1.26

668

959

General symptoms and signs

779

1075

3.66

188.73

2.8

2.4

300.55

295.14

e6/l

0.02

756

1046

Explicit Sepsis, including avohilmo

469

950

4.54

185.86

2.9

2.5

223.85

458.60

e6/l

0.90

452

919

Autoimmune diseases

835

1250

3.42

185.06

2.6

294.60

356.55

e6/l

0.20

817

1216

Explicit Sepsis

459

933

4.54

182.47

2.9

2.5

226.76

465.82

e6/l

0.89

443

902

ILD, hospital admissions 3, with pneumonia sepsis

172

135

13.30

179.33

2.3

2.1

100.40

147.65

e6/l

0.91

167

129

Lymphoid leukaemia

153

106

15.42

172.02

3.3

2.0

2895.99

128.62

e6/l

2.87

147

101

Any event in cancer register

685

1129

3.57

170.72

3.1

2.5

316.04

221.52

e6/l

0.43

672

1098

Azathioprine

208

248

8.60

161.31

2.2

3.1

197.12

405.56

e6/l

0.49

200

241

Any gastric operation

484

516

4.74

159.64

2.8

2.6

271.55

258.47

e6/l

0.04

471

495

GASTRO-related operations

484

516

4.74

159.64

2.8

2.6

271.55

258.47

e6/l

0.04

471

495

Certain infectious and parasitic diseases

636

872

3.68

155.50

2.9

2.3

197.35

386.76

e6/l

1.06

617

847

COPD/asthma related infections

690

1006

3.46

155.12

2.7

2.4

370.31

150.78

e6/l

1.16

670

977

COPD/asthma/ILD related infections

690

1006

3.46

155.12

2.7

2.4

370.31

150.78

e6/l

1.16

670

977

Used for control exclusion in common control thyroid runs

739

1159

3.24

151.24

2.7

2.5

240.69

374.19

e6/l

0.49

719

1130

Any reimbursement code in KELA

349

284

6.20

148.18

3.0

2.5

323.98

189.79

e6/l

0.54

344

275

Viral infections characterized by skin and mucous membrane lesions

426

1086

3.97

146.31

2.7

146.40

387.02

e6/l

1.55

419

1048

Oxycodone

394

804

4.24

141.10

2.4

2.6

218.43

492.90

e6/l

1.04

377

783

Bacterial Sepsis

424

905

3.92

135.23

2.6

2.4

226.94

472.64

e6/l

0.98

408

875

Solid cancers

553

936

3.49

133.79

2.7

2.4

184.82

156.02

e6/l

0.26

541

906

Systemic connective tissue disorders

356

860

4.20

131.93

2.4

2.5

201.91

287.44

e6/l

0.33

342

827

Other interstitial pulmonary diseases

212

338

6.44

126.99

2.3

2.2

101.26

114.49

e6/l

0.37

206

322

Viral Sepsis

243

443

5.59

126.48

2.5

2.3

156.45

450.22

e6/l

0.84

234

428

Interstitial lung disease

212

340

6.40

126.25

2.3

2.2

101.26

114.14

e6/l

0.36

206

323

Interstitial lung disease endpoints

212

340

6.40

126.25

2.3

2.2

101.26

114.14

e6/l

0.36

206

323

Solid cancers, including Hilmo

555

973

3.35

126.16

2.7

2.4

192.37

155.54

e6/l

0.36

543

943

ILD, hospital admissions

210

336

6.42

125.37

2.3

2.2

100.73

114.16

e6/l

0.37

204

319

Implicit viral Sepsis

241

442

5.55

124.63

2.6

2.3

156.81

450.95

e6/l

0.84

232

427

Other respiratory diseases principally affecting the interstitium

229

409

5.73

122.02

2.3

100.57

108.55

e6/l

0.23

222

391

Reimbursement for rheumatic diseases

474

1459

3.26

121.17

2.0

2.7

147.83

339.17

e6/l

1.61

457

1418

Other medical care

414

988

3.55

115.61

2.1

2.7

307.75

269.40

e6/l

0.11

404

953

Viral infections characterized by skin and mucous membrane lesions, including avohilmo

681

1998

2.67

115.19

2.6

171.02

331.27

e6/l

1.67

665

1944

Implicit bacterial Sepsis

361

807

3.88

115.00

2.6

2.4

195.76

509.63

e6/l

1.20

348

779

Bronchitis

765

1800

2.56

111.31

2.9

2.4

366.01

272.65

e6/l

0.29

744

1751

COPD differential diagnosis

468

658

3.59

110.91

2.7

2.6

270.46

163.29

e6/l

0.55

450

643

ILD differential diagnosis

467

658

3.58

110.34

2.7

2.6

270.63

163.29

e6/l

0.55

449

643

Excluding asthma or asthma-COPD overlap

465

661

3.55

108.56

2.7

2.6

271.22

162.98

e6/l

0.55

447

646

Implicit bacterial Sepsis, including avohilmo

380

885

3.61

108.35

2.6

2.4

189.00

480.37

e6/l

1.23

367

855

Implicit viral Sepsis, including avohilmo

280

660

4.29

106.85

2.6

2.4

163.55

463.50

e6/l

1.11

269

635

Other pulmonary diagnosis

461

661

3.51

106.36

2.8

2.6

272.83

162.98

e6/l

0.55

443

646

Asthma, unspecified (mode), excluding more controls

332

593

4.03

105.47

2.4

2.6

205.11

155.63

e6/l

0.30

320

579

Provisional assignment of new diseases of uncertain etiology

437

1394

3.14

104.85

2.3

2.6

594.95

260.76

e6/l

0.82

420

1357

Codes for special purposes

437

1397

3.13

104.45

2.3

2.6

594.95

260.42

e6/l

0.82

420

1359

Persons encountering health services for other counselling and medical advice, not elsewhere classified

741

1558

2.54

102.14

2.6

386.77

260.90

e6/l

0.42

721

1513

Asthma, unspecified (mode)

334

623

3.90

101.66

2.4

2.6

203.87

166.55

e6/l

0.21

322

608

Persons encountering health services for specific procedures and health care

728

1720

2.51

101.27

2.3

2.8

300.37

257.80

e6/l

0.15

708

1678

Acute upper respiratory infections of multiple and unspecified sites

558

1475

2.78

100.09

3.0

2.4

223.29

291.82

e6/l

0.36

544

1433

Covid-19 confirmed case

332

930

3.61

99.56

2.3

2.5

732.15

265.98

e6/l

0.89

323

900

724

1458

2.53

97.55

2.7

2.4

509.58

220.95

e6/l

1.04

704

1414

All influenza

225

484

4.71

96.73

3.2

2.5

467.85

246.75

e6/l

0.33

219

469

ILD, hospital admissions 1, main diag only

176

309

5.84

95.67

2.2

2.1

102.58

120.14

e6/l

0.47

171

295

Polyarthropathies

514

1174

2.83

92.11

2.2

2.8

140.08

362.36

e6/l

1.78

495

1144

Asthma

419

651

3.34

90.98

2.4

2.6

503.76

164.39

e6/l

0.86

407

636

Bacterial pneumonia (organism specified)

354

981

3.30

90.27

2.7

2.5

536.60

237.07

e6/l

0.72

341

945

Asthma, excluding more controls

407

620

3.39

90.19

2.4

2.6

384.56

153.93

e6/l

0.63

397

606

Diagnoses used for exclusion with ILD

248

613

4.11

89.33

2.3

2.6

440.21

221.77

e6/l

0.31

242

591

Neoplasms

459

783

3.09

89.32

3.1

2.5

294.42

159.20

e6/l

0.77

449

766

Implicit Sepsis

516

1410

2.71

88.91

2.4

2.6

182.30

375.73

e6/l

1.27

500

1369

All chronic kidney diseases

421

1131

2.99

88.34

2.5

2.6

306.03

348.65

e6/l

0.11

407

1091

Marginal zone B-cell lymphoma

53.64

88.02

3.7

1.3

291.12

187.00

e6/l

0.29

Asthma (only as main-diagnosis)

388

651

3.35

87.38

2.3

2.6

545.37

164.39

e6/l

0.92

379

636

Asthma (only as main-diagnosis), excluding more controls

380

620

3.41

87.36

2.3

2.6

552.40

153.93

e6/l

0.96

372

606

Dental caries

236

541

4.17

85.43

3.4

2.3

176.66

173.17

e6/l

0.02

231

523

Asthma (mode)

403

658

3.23

84.16

2.4

2.6

515.88

163.29

e6/l

0.87

392

643

Persons encountering health services in other circumstances, wide

709

1559

2.35

82.44

2.6

335.06

276.62

e6/l

0.18

690

1514

Zoster [herpes zoster], including avohilmo

383

1266

2.94

81.97

2.7

2.5

189.65

368.77

e6/l

1.12

374

1222

Renal tubulo-interstitial diseases

590

1784

2.44

81.87

2.7

2.5

381.46

297.35

e6/l

0.24

571

1736

Renal failure

368

1035

3.06

81.49

2.7

2.4

294.48

436.98

e6/l

0.40

360

992

Acute sinusitis

377

1169

2.95

80.11

2.9

2.5

480.25

277.86

e6/l

0.53

370

1136

Persons with potential health hazards related to family and personal history and certain conditions influencing health status

639

1724

2.35

79.23

3.4

2.3

347.81

243.71

e6/l

0.38

625

1676

All kidney diseases

642

1861

2.32

78.47

2.7

2.6

332.92

293.54

e6/l

0.11

620

1814

Disorders of optic nerve and visual pathways

130

207

6.45

78.14

3.7

2.1

311.27

159.56

e6/l

0.37

130

201

Other diseases of pleura

346

991

3.06

77.30

2.4

148.63

497.24

e6/l

1.97

332

955

Mycoses

256

721

3.60

76.55

2.8

2.7

122.63

353.13

e6/l

1.33

249

697

Headache

376

995

2.93

75.99

2.4

2.5

220.49

282.11

e6/l

0.29

368

968

Chronic kidney disease

258

703

3.57

75.63

2.7

2.3

238.78

383.90

e6/l

0.41

252

667

Acute upper respiratory infections

646

1703

2.28

73.89

2.8

2.4

342.93

301.42

e6/l

0.13

631

1653

Infection due to other mycobacteria

38.10

73.72

2.2

1.5

103.70

128.31

e6/l

0.24

Implicit Sepsis, including avohilmo

519

1519

2.45

72.76

2.4

2.6

178.16

376.13

e6/l

1.42

504

1478

Other systemic involvement of connective tissue (FG)

214

542

3.92

72.29

2.5

2.6

264.15

374.26

e6/l

0.25

205

526

Malaise and fatigue

303

751

3.19

71.05

2.3

2.4

135.83

357.46

e6/l

1.41

292

725

Infection due to other mycobacteria, including avohilmo

29.62

69.88

2.1

103.40

115.06

e6/l

0.13

Certain infectious and parasitic diseases, including avohilmo

377

630

3.01

69.41

2.7

2.2

193.01

346.43

e6/l

0.76

361

611

General examination and investigation of persons without complaint and reported diagnosis

395

717

2.88

68.18

3.1

2.2

427.38

183.85

e6/l

0.60

384

701

Donors of organs and tissues

22.16

67.78

3.8

2.2

77.51

148.88

e6/l

1.23

Medical observation and evaluation for suspected diseases and conditions

396

717

2.84

66.46

3.2

2.2

245.38

183.85

e6/l

0.31

380

701

Rheumatoid arthritis

256

687

3.33

66.14

2.0

2.6

100.68

395.34

e6/l

1.68

246

664

Other acute lower respiratory infections

377

1366

2.65

66.02

2.8

2.6

539.55

255.17

e6/l

0.54

366

1324

Seropositive rheumatoid arthritis

203

537

3.80

65.98

1.9

2.6

98.87

374.75

e6/l

1.23

194

521

Oedema, not elsewhere classified

207

554

3.68

64.01

2.6

2.4

225.53

284.09

e6/l

0.20

196

531

Other reaction to severe stress, and adjustment disorders

284

959

2.99

62.99

3.1

2.6

202.19

295.18

e6/l

0.50

277

944

Osteopathies and chondropathies

389

1404

2.55

62.62

2.6

139.99

344.83

e6/l

1.76

375

1362

Other systemic involvement of connective tissue

223

661

3.41

61.72

2.5

257.12

318.89

e6/l

0.15

214

635

Other and unspecified dermatitis

368

1445

2.57

61.15

2.6

268.86

300.58

e6/l

0.10

359

1403

Condition for Implicit Sepsis (Organ dysfunction codes)

509

1545

2.29

61.15

2.4

2.6

173.52

372.89

e6/l

1.46

494

1505

Asthma-related pneumonia

275

925

2.99

61.12

2.3

2.5

702.20

369.48

e6/l

0.45

268

887

Cough

296

963

2.89

61.06

2.4

2.7

462.96

248.22

e6/l

0.41

286

935

Symptoms and signs involving the skin and subcutaneous tissue

474

1964

2.29

60.80

2.9

2.5

309.49

287.96

e6/l

0.05

465

1907

Asthma-related pneumonia or sepsis

275

928

2.98

60.77

2.3

2.5

702.20

368.73

e6/l

0.45

268

890

Asthma, hospital admissions 3, pneumonia

275

928

2.98

60.77

2.3

2.5

702.20

368.73

e6/l

0.45

268

890

Osteoporosis

211

553

3.55

60.57

2.6

2.3

118.58

408.54

e6/l

1.26

202

532

Sulfasalazine

183

488

3.78

59.35

2.2

3.2

268.59

460.73

e6/l

0.42

176

475

Use of teriflunomide

23.39

59.28

3.3

2.0

141.59

164.00

e6/l

0.16

Rheumatoid arthritis, including avohilmo

275

955

2.91

58.17

2.0

2.6

102.53

341.65

e6/l

1.88

264

921

Acute bronchitis

290

1016

2.82

57.89

2.8

2.6

647.28

290.18

e6/l

0.51

281

981

Any death

423

1227

2.43

57.73

2.2

2.6

131.38

389.71

e6/l

1.87

409

1185

Secondary malignant neoplasm of other and unspecified sites, including Hilmo

150

342

4.29

57.26

1.8

2.1

128.13

159.44

e6/l

0.36

145

326

Malignant neoplasm of respiratory system and intrathoracic organs, including Hilmo

143

257

4.62

56.68

2.2

2.0

201.03

166.68

e6/l

0.14

138

244

Dermatitis

410

1717

2.35

56.14

2.6

306.84

281.92

e6/l

0.08

400

1669

Condition for Implicit Sepsis (Organ dysfunction codes), including avohilmo

520

1607

2.19

55.99

2.5

2.6

176.13

365.23

e6/l

1.43

503

1570

Use of fingolimod

22.60

55.56

3.7

2.2

97.90

192.67

e6/l

1.34

Neurological diseases

479

1034

2.34

54.98

2.7

2.5

290.93

283.16

e6/l

0.02

463

1014

Herpesviral [herpes simplex] infections, including avohilmo

204

619

3.33

54.45

2.6

2.8

143.81

303.86

e6/l

1.17

197

601

Symptoms and signs involving the nervous and musculoskeletal systems

383

1622

2.38

54.05

2.7

2.6

201.52

306.57

e6/l

0.59

376

1572

Heart failure, not strict

463

1378

2.27

54.03

2.5

2.7

158.84

304.23

e6/l

1.15

441

1344

Asthma, hospital admission 2, infections

391

1628

2.36

53.86

2.3

2.6

532.10

290.34

e6/l

0.48

383

1583

Asthma-related infections

391

1628

2.36

53.86

2.3

2.6

532.10

290.34

e6/l

0.48

383

1583

Dyspnoea

548

1892

2.10

53.74

2.2

2.7

362.05

295.07

e6/l

0.20

531

1840

Finngen Rheumatological endpoints

550

1469

2.13

53.00

2.5

2.8

208.16

350.43

e6/l

0.94

529

1442

Abnormalities of breathing

525

1395

2.16

52.36

2.2

2.7

389.07

249.22

e6/l

0.57

508

1364

Diseases of the respiratory system

315

562

2.82

52.19

2.5

2.4

220.95

169.23

e6/l

0.25

300

550

Bacterial pneumoniae

239

705

3.00

51.95

2.6

2.4

759.14

190.93

e6/l

1.05

228

678

Symptoms, signs and abnormal clinical and laboratory findings, not elsewhere classified

172

202

4.29

51.47

3.1

2.3

147.41

139.87

e6/l

0.15

167

193

Seropositive rheumatoid arthritis, wide

203

640

3.21

50.95

1.9

2.5

98.87

370.63

e6/l

1.43

194

616

Other/unspecified seropositive rheumatoid arthritis

201

637

3.19

50.03

1.9

2.5

98.76

372.05

e6/l

1.43

192

613

Other/unspecified seropositive rheumatoid arthritis (ICD-10)

199

630

3.19

49.63

1.9

2.5

99.53

374.96

e6/l

1.42

190

606

Complications of surgical and medical care, not elsewhere classified

588

1972

2.00

49.62

3.2

2.4

232.30

322.44

e6/l

0.49

568

1922

Other bacterial intestinal infections

154

414

3.77

49.55

3.3

2.5

152.54

187.94

e6/l

0.20

145

401

Enterocolitis due to Clostridium difficile

110

232

4.83

48.79

3.2

2.1

123.83

138.78

e6/l

0.15

102

223

Nutritional anaemias

320

1250

2.46

48.23

2.7

2.5

291.76

354.38

e6/l

0.16

308

1211

Other special examinations and investigations of persons without complaint or reported diagnosis

355

717

2.52

47.91

2.7

2.2

204.98

183.85

e6/l

0.09

342

701

Dermatitis and eczema

647

2000

1.92

47.65

2.7

2.5

331.04

291.89

e6/l

0.13

632

1945

Opioids

532

1321

2.09

47.38

2.4

2.7

206.48

363.78

e6/l

0.91

513

1296

Iron deficiency anaemia

283

1086

2.57

47.36

2.6

2.4

318.43

375.04

e6/l

0.12

272

1049

Other disorders of lacrimal gland

264

1007

2.64

46.78

2.9

2.5

184.91

220.20

e6/l

0.25

257

973

Glomerular diseases

155

439

3.58

46.23

2.1

2.7

126.38

188.21

e6/l

0.43

150

421

Intestinal infectious diseases

555

2104

1.97

46.12

2.8

2.5

218.27

322.75

e6/l

0.60

536

2053

Bacterial intestinal infections, IBD co-morbidities

152

426

3.61

46.03

3.3

2.5

154.80

178.25

e6/l

0.13

143

409

Complications of medical and surgical care

448

1927

2.10

46.02

3.5

2.4

284.82

308.88

e6/l

0.08

432

1874

Venous thromboembolism

332

1373

2.34

45.19

2.3

2.5

204.10

353.09

e6/l

0.69

323

1323

Diseases of the skin and subcutaneous tissue

532

1304

2.05

45.15

2.7

2.6

184.36

224.19

e6/l

0.28

512

1268

Other heart diseases

289

728

2.59

44.60

2.6

3.1

164.05

214.94

e6/l

0.40

281

718

Noninfective enteritis and colitis

304

1278

2.39

43.67

2.5

2.7

200.32

303.80

e6/l

0.50

296

1237

Other malignant neoplasms of skin (=non-melanoma skin cancer)

213

487

2.98

43.01

2.4

2.1

415.95

150.57

e6/l

0.51

200

465

Disorders of lacrimal system

293

1204

2.41

42.71

2.9

2.5

182.31

282.14

e6/l

0.65

285

1163

Other malignant neoplasms of skin (=non-melanoma skin cancer), including Hilmo

219

508

2.92

42.64

2.3

2.2

482.77

148.55

e6/l

0.70

208

486

292

1210

2.41

42.63

2.3

2.7

601.99

313.12

e6/l

0.43

285

1175

Malignant neoplasm of skin, including Hilmo

240

583

2.77

42.37

2.3

2.2

214.27

148.35

e6/l

0.44

229

559

Tramadol

428

1214

2.13

41.79

2.3

2.7

211.51

378.65

e6/l

0.84

414

1190

Malignant neoplasm of skin

228

550

2.82

41.69

2.4

2.2

374.65

149.21

e6/l

0.46

216

526

Disorders of other endocrine glands

283

1164

2.41

41.23

2.6

129.25

307.39

e6/l

1.64

277

1126

Erysipelas

282

1003

2.43

41.05

2.1

2.4

398.47

396.84

e6/l

0.00

270

972

Gout, FINNGEN

191

660

2.90

40.40

2.4

150.70

396.50

e6/l

0.93

183

634

Infections of the skin and subcutaneous tissue

368

1707

2.13

40.13

2.1

2.7

531.50

278.17

e6/l

0.67

361

1656

Chronic sinusitis

272

1140

2.40

39.41

2.4

2.7

490.91

245.57

e6/l

0.56

263

1104

Erysipelas, including avohilmo

350

1180

2.21

39.34

2.2

2.5

333.47

392.57

e6/l

0.12

337

1148

Gout

191

573

2.88

38.70

2.4

2.6

150.70

575.69

e6/l

1.62

183

550

Other infectious diseases, including avohilmo

195

4.64

37.80

2.9

2.3

190.73

164.86

e6/l

0.15

185

Presence of other functional implants

338

1049

2.22

37.72

2.3

2.2

438.43

296.52

e6/l

0.24

330

1009

Codeine

477

1308

1.98

37.43

2.6

214.67

366.09

e6/l

0.81

457

1283

Other arthritis (FG)

195

718

2.74

37.17

2.3

2.8

161.50

368.01

e6/l

0.94

189

700

Basal cell carcinoma, including Hilmo

203

491

2.81

37.06

2.3

2.1

439.25

150.65

e6/l

0.53

191

469

Other bacterial intestinal infections, including avohilmo

169

578

2.95

37.00

3.4

2.5

149.80

361.36

e6/l

0.87

160

562

Cardiovascular diseases (excluding rheumatic etc)

350

911

2.21

36.95

2.5

3.0

236.58

213.09

e6/l

0.11

343

900

Diarrhoea and gastroenteritis of presumed infectious origin

402

1794

2.01

36.80

2.7

2.5

236.86

312.00

e6/l

0.30

392

1753

Other (seronegative) rheumatoid arthritis, wide

145

456

3.22

36.73

1.9

2.5

85.09

350.05

e6/l

1.04

138

438

Candidiasis, including avohilmo

206

791

2.63

36.17

2.6

128.71

384.60

e6/l

1.60

200

768

DVT of lower extremities and pulmonary embolism

252

1059

2.38

36.09

2.4

2.5

231.48

366.50

e6/l

0.43

245

1017

Bacterial pneumonia, not elsewhere classified

199

650

2.70

36.07

2.5

2.4

508.62

194.91

e6/l

0.80

188

623

Diseases of oesophagus, stomach and duodenum

575

1871

1.82

36.05

2.4

2.7

193.94

317.91

e6/l

0.90

560

1820

Basal cell carcinoma

194

472

2.82

35.58

2.3

2.1

581.25

152.19

e6/l

0.76

182

450

Gastro-oesophageal reflux disease

393

1662

2.00

35.34

2.3

2.7

304.00

325.14

e6/l

0.05

384

1612

Other medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

245

4.07

35.13

8.0

2.2

449.07

153.32

e6/l

0.67

233

Visual disturbances and blindness

313

1462

2.15

35.09

2.6

2.5

356.81

316.01

e6/l

0.11

305

1415

Other and unspecified iron deficiency

214

862

2.49

33.88

2.8

2.4

285.03

358.00

e6/l

0.14

205

829

Other disorders of fluid, electrolyte and acid-base balance

203

753

2.56

33.43

2.1

2.4

543.13

309.75

e6/l

0.28

196

729

Symptoms and signs involving the urinary system

432

1710

1.91

33.33

2.8

2.6

213.13

343.80

e6/l

0.84

418

1662

Other specified/unspecified arthritis

177

660

2.70

33.00

2.3

2.7

166.06

384.69

e6/l

0.88

172

636

Heart failure,strict

301

966

2.19

32.70

2.2

2.6

422.36

355.37

e6/l

0.09

284

937

5-aminosalicylic acid

122

380

3.23

31.42

2.1

3.3

307.00

304.51

e6/l

0.00

117

372

Other diseases of intestines

560

1777

1.76

31.17

2.6

215.57

313.81

e6/l

0.70

546

1734

Waldenstrom macroglobulinemia, lymphoplasmacytic lymphoma, including Hilmo

58.53

31.14

3.0

1.4

44.78

179.43

e6/l

—

Biological medication for rheuma

136

457

3.01

30.85

1.8

2.8

136.62

279.80

e6/l

0.83

131

443

Symptoms and signs involving the circulatory and respiratory systems

507

1398

1.82

30.81

2.6

2.7

299.39

249.02

e6/l

0.19

489

1367

Parasetamol

351

865

2.06

30.27

2.6

2.7

332.91

339.60

e6/l

0.01

342

845

Visual disturbances

286

1371

2.10

30.17

2.6

293.61

309.99

e6/l

0.05

279

1325

Disorders of eyelid, lacrimal system and orbit

473

1932

1.80

30.08

2.8

2.5

314.58

298.24

e6/l

0.04

461

1875

Other respiratory disorders and diseases

140

485

2.91

30.06

2.4

2.5

167.53

171.52

e6/l

0.02

133

464

Other diseases of the respiratory system

140

485

2.91

30.06

2.4

2.5

167.53

171.52

e6/l

0.02

133

464

Other disorders of skin and subcutaneous tissue

399

1808

1.87

29.44

2.5

2.6

436.83

286.00

e6/l

0.31

391

1750

Diseases of veins, lymphatic vessels and lymph nodes, not elsewhere classified (FINNGEN)

239

650

2.33

29.42

2.4

3.1

226.13

221.87

e6/l

0.01

231

641

Syncope and collapse

199

681

2.45

29.36

2.2

2.5

276.92

382.38

e6/l

0.28

190

655

Other heart diseases, wide

481

1629

1.79

29.02

2.5

2.8

194.53

300.22

e6/l

0.72

464

1598

Chronic lower respiratory diseases

624

1963

1.68

29.00

2.4

2.7

394.00

249.61

e6/l

0.47

606

1914

Gastrointestinal diseases

286

655

2.20

28.93

2.6

2.5

242.05

364.16

e6/l

0.37

276

635

Disorders of sclera, cornea, iris and ciliary body

314

1587

1.99

28.66

2.4

2.7

201.26

301.11

e6/l

0.63

305

1540

Metabolic disorders

496

1691

1.76

28.38

2.6

2.7

372.49

282.93

e6/l

0.23

477

1651

Persons encountering health services for examination and investigation

303

717

2.13

28.38

2.9

2.2

220.12

183.85

e6/l

0.14

290

701

Cardiovascular diseases

311

793

2.09

28.28

2.6

3.0

247.84

223.57

e6/l

0.10

304

787

Acute tubulo-interstitial nephritis

323

1387

1.97

28.02

2.5

534.71

320.78

e6/l

0.41

311

1347

Symptoms and signs involving the digestive system and abdomen

501

1422

1.77

27.79

2.8

2.5

191.92

328.07

e6/l

0.85

486

1374

Neurotic, stress-related and somatoform disorders

473

1858

1.76

27.58

2.8

2.6

255.34

252.75

e6/l

0.01

460

1810

Hypothyroidism, strict autoimmune

305

985

2.04

27.51

2.4

2.5

148.36

396.79

e6/l

1.75

293

958

Tumor necrosis factor alpha inhibitors

121

409

2.99

27.23

1.8

2.7

142.24

295.74

e6/l

0.78

116

397

Asthma (diagnoses ohter than nonallergic)

464

2157

1.74

27.01

2.3

2.6

297.28

305.30

e6/l

0.02

450

2101

Diseases of the eye and adnexa

394

1050

1.89

26.69

2.8

2.5

225.43

208.43

e6/l

0.08

386

1027

Iridocyclitis

151

585

2.60

26.23

2.2

2.8

252.64

235.87

e6/l

0.05

146

565

Other functional intestinal disorders

252

1098

2.09

26.14

2.6

2.5

177.05

338.35

e6/l

1.11

242

1061

Abdominal and pelvic pain

493

1422

1.75

26.13

2.8

2.5

317.22

328.07

e6/l

0.02

480

1374

Anxiety disorders

473

1880

1.73

26.11

2.8

2.6

255.34

250.85

e6/l

0.02

460

1832

Surgical and other medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

326

1695

1.89

25.74

4.0

2.4

344.82

327.52

e6/l

0.05

318

1647

Intestinal infectious diseases, including avohilmo, including avohilmo

582

1971

1.65

25.70

2.8

2.5

242.70

321.71

e6/l

0.37

561

1925

Inflammatory bowel disease

193

852

2.28

25.16

2.3

2.9

238.26

250.96

e6/l

0.03

187

825

Abnormal findings on examination of blood, without diagnosis

275

1255

1.99

24.90

2.8

2.5

373.39

358.33

e6/l

0.03

270

1208

Squamous cell neoplasms and carcinomas of the skin

5.37

24.88

2.6

1.8

76.65

126.65

e6/l

1.79

Mycoses, including avohilmo

480

2196

1.67

23.69

2.5

2.6

297.52

287.93

e6/l

0.02

466

2140

Heart failure, strict

307

1120

1.91

23.51

2.1

2.6

414.58

366.38

e6/l

0.07

290

1083

Kidney transplant status

121

4.64

23.41

2.3

2.6

75.69

151.62

e6/l

2.77

116

All-cause Heart Failure

303

1104

1.92

23.36

2.1

2.5

418.36

370.48

e6/l

0.06

287

1067

Codeine or tramadol medication

563

1891

1.62

23.23

2.5

2.6

202.82

327.04

e6/l

0.86

539

1852

Anxiety disorders, excluding more controls

435

1635

1.70

22.52

2.9

2.5

262.25

319.25

e6/l

0.25

422

1596

Chronic apical periodontitis

552

1932

1.61

22.12

2.5

2.6

287.55

299.40

e6/l

0.03

533

1883

Waldenstrom macroglobulinemia, lymphoplasmacytic lymphoma

50.11

22.06

3.5

1.5

57.42

199.33

e6/l

—

Valvular heart disease excluding rheumatic fever

246

881

2.00

21.66

2.3

2.7

273.55

381.03

e6/l

0.31

236

857

Covid-19 suspected case

131

526

2.51

21.22

2.3

2.8

392.99

211.59

e6/l

0.28

123

516

Unspecified kidney failure

200

3.54

20.85

2.6

2.1

652.77

150.20

e6/l

0.52

187

Episodal and paroxysmal disorders

526

1662

1.61

20.82

2.4

2.7

486.68

277.09

e6/l

0.66

509

1625

Diarrhoea and gastroenteritis of presumed infectious origin, including avohilmo

496

1980

1.61

20.72

2.8

2.5

268.25

320.72

e6/l

0.20

481

1934

Other or unspecified common variable immunodeficiency

36.02

20.64

2.8

1.2

115.77

179.11

e6/l

—

Bleeding

415

1741

1.68

20.62

2.5

2.6

237.96

354.74

e6/l

0.51

400

1692

Localized swelling, mass and lump of skin and subcutaneous tissue

183

859

2.14

20.62

2.8

2.5

201.21

290.99

e6/l

0.50

178

829

Seronegative rheumatoid arthritis

246

3.24

20.56

1.9

2.7

89.51

432.58

e6/l

0.70

240

Other complications of surgical and medical care, not elsewhere classified

227

3.34

20.45

2.1

2.5

92.16

154.42

e6/l

1.98

218

Diseases of the digestive system

237

1219

1.94

20.27

2.2

2.6

145.48

391.19

e6/l

1.76

229

1173

Common variable immunodeficiency

21.90

20.09

2.6

1.3

855.86

198.20

e6/l

0.42

Asthma, hospital admissions , main diagnosis only

407

2146

1.65

19.99

2.2

2.6

526.40

267.29

e6/l

0.56

398

2088

Non-rheumatic valve diseases

240

877

1.96

19.97

2.3

2.7

270.93

382.52

e6/l

0.32

230

853

Diseases of the musculoskeletal system and connective tissue

242

606

2.01

19.79

2.7

2.8

246.77

537.20

e6/l

0.84

231

596

Low back pain

393

1589

1.67

19.35

2.7

2.6

202.33

353.29

e6/l

0.83

380

1555

Malignant neoplasm of head and neck

104

4.47

18.90

2.1

530.33

149.43

e6/l

0.38

Viral infections of the central nervous system, including avohilmo

171

3.61

18.76

3.4

2.4

325.21

136.45

e6/l

0.55

166

Other specific joint derangements/joint disorders

357

1308

1.71

18.55

2.4

2.8

213.81

327.12

e6/l

0.73

349

1278

Intracranial trauma

244

869

1.90

18.45

2.5

145.48

248.98

e6/l

0.88

236

853

Dental operations

271

746

1.87

18.36

2.6

2.3

227.55

203.63

e6/l

0.08

264

719

Other soft tissue disorders, not elsewhere classified

454

1615

1.60

18.24

2.5

2.7

262.20

347.22

e6/l

0.35

441

1575

Other disorders of urethra and urinary system

346

1421

1.70

18.14

2.6

2.4

186.44

371.77

e6/l

0.94

333

1377

Use of hypnotics and sedatives

516

1904

1.55

18.13

2.7

2.6

187.49

332.14

e6/l

1.05

498

1860

Complications of procedures, not elsewhere classified

387

1914

1.63

17.92

2.2

2.4

294.87

327.91

e6/l

0.11

373

1864

Heart failure and antihypertensive medication

145

410

2.31

17.92

2.5

2.7

197.28

156.05

e6/l

0.20

137

401

Disorders of lens

331

1197

1.72

17.75

2.7

2.6

235.05

261.80

e6/l

0.10

326

1159

Diseases of vocal cords and larynx+other diseases of upper respiratory tract, no elsewhere classified

266

1446

1.78

17.41

2.0

2.6

176.26

251.28

e6/l

0.63

259

1403

Hypo-osmolality and hyponatraemia

104

409

2.54

17.38

2.5

2.4

955.64

144.44

e6/l

0.63

392

Non-ischemic cardiomyopathy

168

643

2.08

16.95

2.3

2.5

198.21

370.07

e6/l

0.63

158

623

Haemorrhage from respiratory passages

170

735

2.06

16.95

2.5

162.98

305.95

e6/l

0.65

164

709

Use of dimethyl fumarate

19.21

16.75

4.3

2.5

157.24

207.86

e6/l

0.28

Nerve, nerve root and plexus disorders

510

2014

1.52

16.72

2.4

2.6

329.14

296.49

e6/l

0.08

492

1963

Antihypertensive medication - note that there are other indications

299

891

1.76

16.67

2.5

2.8

358.09

174.78

e6/l

0.66

293

878

Other diseases of urinary system

477

1735

1.55

16.50

3.0

2.5

225.40

334.47

e6/l

0.58

465

1686

Skin changes due to chronic exposure to nonionizing radiation

189

880

1.95

16.40

2.2

1048.04

246.27

e6/l

0.83

180

842

Pain in joint

277

967

1.76

16.26

2.3

2.6

235.09

367.65

e6/l

0.58

270

939

Pain in throat and chest

374

1367

1.62

16.05

2.6

2.7

234.01

250.37

e6/l

0.07

364

1336

Benzodiazepine use

484

2159

1.52

15.88

2.8

2.5

158.92

331.42

e6/l

2.13

466

2107

Actinic keratosis

182

854

1.95

15.70

2.1

2.2

1083.09

250.69

e6/l

0.82

173

817

Diseases of veins, lymphatic vessels and lymph nodes, not elsewhere classified

456

1882

1.53

15.63

2.3

2.6

324.61

316.50

e6/l

0.02

435

1837

Hepatomegaly and splenomegaly, not elsewhere classified

15.65

15.58

3.0

1.5

119.60

180.65

e6/l

0.50

196

938

1.89

15.39

2.2

2.3

1014.71

236.92

e6/l

0.84

187

899

Preparatory care for dialysis

4.24

15.35

2.0

1.7

327.28

159.46

e6/l

0.28

Malignant neoplasm of tonsil and base of tongue, including Hilmo

7.12

15.31

2.1

2.2

989.48

166.18

e6/l

0.41

Ulcerative colitis

130

615

2.13

14.53

2.1

2.8

299.99

243.48

e6/l

0.11

125

596

Human immunodeficiency virus [HIV] disease resulting in infectious and parasitic diseases

36.52

14.50

6.3

1.5

234.89

188.50

e6/l

—

Asthma, including avohilmo

552

2089

1.46

14.42

2.3

2.6

430.92

268.25

e6/l

0.44

533

2039

Atrial fibrillation and flutter

145

448

2.10

14.33

2.7

3.2

146.36

251.71

e6/l

0.59

140

441

Hypokalaemia

274

2.72

14.30

1.8

2.5

993.92

131.18

e6/l

0.50

266

Pain in limb

388

1587

1.56

14.27

2.5

2.7

191.66

335.42

e6/l

0.83

377

1547

Diseases of the ear and mastoid process

526

1792

1.47

14.25

2.5

2.7

311.26

272.88

e6/l

0.11

513

1745

Concussion

203

862

1.83

14.18

2.5

147.60

243.42

e6/l

0.79

197

846

Acute pharyngitis

312

2.59

14.15

2.5

2.7

318.15

138.89

e6/l

1.40

305

Diseases of liver

182

981

1.86

14.04

2.3

2.7

134.51

302.55

e6/l

1.28

177

947

Constipation

420

1876

1.52

14.03

2.3

2.6

288.60

320.63

e6/l

0.12

404

1827

Disorders of choroid and retina

380

1728

1.54

13.69

2.3

2.6

283.12

332.85

e6/l

0.16

368

1675

Sleep apnoea

443

1871

1.50

13.55

2.2

2.7

340.64

299.63

e6/l

0.13

431

1823

Acute suppurative otitis media

140

649

2.02

13.54

2.6

2.8

184.64

247.53

e6/l

0.37

140

637

Arthropathies

401

1324

1.53

13.20

2.4

2.8

230.91

343.30

e6/l

0.56

389

1294

Hypertension, essential

354

1280

1.57

13.12

2.2

2.9

138.13

327.25

e6/l

1.63

343

1249

Any mental disorder, or suicide (or attempt), or psychic disorders complicating pregnancy, partum or puerperum or nerve system disorders, excluding more controls

135

670

2.00

12.83

2.5

2.6

139.08

221.16

e6/l

0.78

127

658

Seborrhoeic dermatitis

211

2.87

12.82

2.9

2.6

975.25

272.97

e6/l

0.37

203

Lower back pain or/and sciatica

499

2151

1.44

12.81

2.7

2.5

190.65

324.32

e6/l

1.01

483

2097

Hypertension

357

1302

1.55

12.63

2.3

2.8

139.61

326.10

e6/l

1.64

345

1271

Continuous positive airway pressure

355

2.29

12.61

2.2

2.8

167.65

449.30

e6/l

0.75

350

Disorders of gallbladder, biliary tract and pancreas

453

1928

1.46

12.53

2.5

2.6

142.10

347.28

e6/l

2.40

443

1871

Senile cataract

287

1078

1.62

12.52

2.6

2.5

275.41

241.58

e6/l

0.11

282

1041

Examination and observation for other reasons

221

715

1.75

12.48

2.6

2.2

224.84

183.99

e6/l

0.24

212

699

Hypertensive diseases

356

1302

1.55

12.46

2.3

2.8

139.43

326.10

e6/l

1.64

344

1271

Benign neoplasms

451

1674

1.47

12.33

2.4

2.6

175.24

320.44

e6/l

1.29

439

1630

Dorsalgia

447

1617

1.47

12.10

2.6

229.48

350.09

e6/l

0.61

433

1583

Other diseases of upper respiratory tract

482

1740

1.45

12.05

2.6

444.15

263.59

e6/l

0.48

470

1689

Other antidepressants

468

1645

1.45

12.04

2.6

2.5

199.99

343.89

e6/l

0.87

451

1611

malignant neoplasm of male genital organs, including Hilmo

103

276

2.25

11.96

2.8

2.3

81.24

130.16

e6/l

3.03

268

Papulosquamous disorders

191

1106

1.73

11.69

2.4

2.7

147.35

277.32

e6/l

0.99

185

1067

Hard cardiovascular diseases

377

1488

1.50

11.66

2.2

2.8

262.33

297.88

e6/l

0.12

365

1450

Depression

438

2025

1.45

11.64

2.8

2.6

240.28

288.06

e6/l

0.24

425

1974

Polymyalgia rheumatica

275

2.53

11.59

2.1

87.31

238.26

e6/l

0.61

261

Endocrine, nutritional and metabolic diseases

353

1167

1.53

11.58

2.8

2.6

229.33

283.18

e6/l

0.24

338

1147

Disorders of conjunctiva

384

2018

1.48

11.56

2.6

257.90

275.36

e6/l

0.06

375

1965

Mood disorders, excluding more controls

430

1736

1.46

11.55

2.8

2.5

244.05

351.63

e6/l

0.55

416

1695

Psoriasis

144

772

1.87

11.41

2.5

2.7

140.20

267.58

e6/l

1.13

139

743

Diseases of oral cavity, salivary glands and jaws

237

730

1.68

11.36

2.4

2.3

145.43

317.01

e6/l

1.05

232

705

Gout, unspecified

104

499

2.10

11.33

2.6

2.3

108.57

271.93

e6/l

0.53

478

Abnormalities of heart beat

155

828

1.82

11.19

1.9

2.6

259.66

258.53

e6/l

0.00

149

802

Diseases of the myoneural junction and muscle

292

2.45

11.18

2.3

2.5

110.35

137.25

e6/l

0.60

282

Other disorders of ear

415

1850

1.45

11.13

2.3

2.7

335.02

276.22

e6/l

0.14

406

1796

Mood disorders

464

2092

1.42

11.03

2.8

2.5

237.45

309.13

e6/l

0.39

449

2039

Care involving use of rehabilitation procedures

255

1446

1.59

11.02

2.4

2.8

291.33

269.44

e6/l

0.05

243

1405

Mood [affective] disorders

462

2088

1.42

10.95

2.8

2.5

238.33

309.50

e6/l

0.39

447

2035

Diseases of arteries, arterioles and capillaries (FINNGEN)

109

362

2.09

10.92

2.2

3.2

88.47

271.56

e6/l

1.07

104

356

Gout, idiopatic and unspecified

122

630

1.95

10.86

2.4

2.3

143.79

318.38

e6/l

0.66

114

608

Exposure to unspecified factor

463

2232

1.41

10.82

2.3

2.6

288.50

290.02

e6/l

0.00

447

2178

Urinary track infection

248

762

1.63

10.74

2.8

2.4

583.29

181.37

e6/l

0.79

242

745

Inflammatory diseases of female pelvic organs

265

1150

1.58

10.71

2.2

2.6

525.25

216.91

e6/l

0.60

257

1125

Other cataract

201

889

1.69

10.64

2.5

297.77

310.39

e6/l

0.03

196

854

Heart failure and coronary heart disease

199

825

1.69

10.62

2.0

2.5

522.81

390.60

e6/l

0.13

190

793

malignant neoplasm of male genital organs

272

2.18

10.60

2.8

2.3

84.10

131.14

e6/l

2.69

264

Keratitis

171

989

1.74

10.57

2.5

2.7

213.80

330.33

e6/l

0.53

166

956

Malignant neoplasm of bone and articular cartilage, including Hilmo

10.24

10.56

1.7

71.30

196.05

e6/l

1.54

Diseases of pulp and periapical tissues, including avohilmo

455

1656

1.42

10.53

2.4

2.6

314.98

341.68

e6/l

0.05

440

1614

Asthma/COPD (KELA code 203)

419

1959

1.43

10.51

2.3

2.7

503.89

249.75

e6/l

0.57

406

1910

Retention of urine

160

728

1.78

10.49

2.2

2.4

241.71

406.83

e6/l

0.45

149

701

Heart failure and bmi 25plus

167

629

1.78

10.42

2.2

2.6

177.44

463.00

e6/l

1.06

156

612

Sequelae with surgical and medical care as external cause

107

537

2.00

10.37

3.1

2.5

122.83

170.17

e6/l

0.36

101

519

Acute lymphocytic leukaemia

24.51

10.35

6.4

3.3

247.21

256.50

e6/l

—

Acute lymphocytic leukaemia, helper endpoint

24.51

10.35

6.4

3.3

247.21

256.50

e6/l

—

Acute lymphocytic leukaemia, including Hilmo

24.51

10.35

6.4

3.3

247.21

256.50

e6/l

—

Malignant neoplasm of tonsil

10.88

10.34

1.7

1.3

1188.89

175.61

e6/l

0.42

Sequelae of external causes of morbidity and mortality

131

705

1.87

10.32

3.0

2.5

128.91

371.33

e6/l

1.24

124

680

Diseases of pulp and periapical tissues and dental caries

272

886

1.58

10.31

2.5

2.4

237.51

295.38

e6/l

0.19

265

857

Other neurological diseases

324

1688

1.49

10.31

2.6

259.83

341.98

e6/l

0.33

316

1634

Spondylopathies

344

1370

1.49

10.30

2.3

2.6

244.20

384.82

e6/l

0.58

327

1337

In situ neoplasms

182

1081

1.69

10.22

2.6

2.4

690.59

262.46

e6/l

0.55

175

1042

Conjunctivitis

342

1877

1.47

10.17

2.6

273.96

280.54

e6/l

0.02

334

1829

Malignant neoplasm of tonsil and base of tongue

8.60

10.09

2.1

2.3

1077.57

169.44

e6/l

0.42

Malignant neoplasm of heart, mediastinum and pleura, including Hilmo

11.50

10.09

2.2

2.9

78.44

145.75

e6/l

0.67

Ischemic heart diseases

363

1479

1.46

10.06

2.1

2.8

251.94

317.21

e6/l

0.24

351

1441

Other/unspecified dorsalgia

171

992

1.71

9.99

2.5

2.7

405.08

379.11

e6/l

0.04

164

969

Complications of internal orthopaedic prosthetic devices, implants and grafts

106

538

1.98

9.96

2.0

2.2

334.12

509.60

e6/l

0.23

509

Malignant neoplasm of bone and articular cartilage of other and unspecified sites

27.56

9.94

2.0

3.0

31.15

196.00

e6/l

—

Other joint disorders

370

1322

1.46

9.93

2.5

2.8

244.82

343.75

e6/l

0.45

361

1292

GI-bleeding

142

793

1.80

9.92

2.5

166.57

475.17

e6/l

1.32

136

758

Phlebitis and thrombophlebitis (not including DVT)

112

581

1.94

9.88

2.2

2.7

116.55

348.63

e6/l

1.05

105

565

Other disorders of optic [2nd] nerve and visual pathways

125

3.15

9.88

3.1

2.1

765.44

120.26

e6/l

0.50

120

Cardiac arrhythmias

264

1091

1.55

9.86

2.6

2.9

232.06

308.47

e6/l

0.28

255

1072

Malignant neoplasm of prostate, including Hilmo

255

2.16

9.85

2.7

2.3

81.48

131.42

e6/l

2.82

247

Malignant neoplasm of oropharynx

9.29

9.58

1.7

1.3

1188.89

169.81

e6/l

0.42

295

2.32

9.56

2.5

2.8

180.97

255.06

e6/l

0.23

289

Caries of dentine, including avohilmo

326

1122

1.49

9.53

2.5

2.4

205.42

271.17

e6/l

0.29

320

1083

Pain (limb, back, neck, head abdominally)

296

984

1.51

9.26

2.8

2.6

229.52

387.95

e6/l

0.58

285

955

Dental caries, including avohilmo

302

1033

1.50

9.19

2.5

2.4

212.33

277.74

e6/l

0.26

296

997

COPD, hospital admission 2, with asthma infections

143

702

1.76

9.13

2.0

2.4

319.12

462.22

e6/l

0.27

138

673

Pneumonia due to Haemophilus influenzae

20.10

9.10

2.6

1.7

51.23

271.71

e6/l

—

Sleep apnoea, including avohilmo

441

1929

1.38

9.07

2.1

2.7

339.59

288.04

e6/l

0.17

427

1882

All anxiety disorders

268

1383

1.51

9.03

2.9

2.7

178.96

273.35

e6/l

0.82

259

1357

Percutaneous Coronary Intervention

339

1425

1.45

9.02

2.1

2.8

286.45

323.19

e6/l

0.11

323

1388

Other diseases of the digestive system

139

795

1.75

9.01

2.5

137.18

473.82

e6/l

1.56

133

760

Drug-induced systemic lupus erythematosus

13.23

8.99

2.0

2.3

32.27

206.17

e6/l

1.98

Follow-up examination after treatment for conditions other than malignant neoplasms

158

612

1.72

8.97

2.7

2.2

415.93

192.85

e6/l

0.60

153

598

Genitourinary diseases

240

768

1.57

8.96

3.1

2.5

138.67

345.20

e6/l

1.50

233

751

Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

254

1684

1.51

8.93

2.4

2.5

384.26

311.78

e6/l

0.18

246

1633

Any mental disorder, or suicide (or attempt), or psychic disorders complicating pregnancy, partum or puerperium or nerve system disorders

135

768

1.76

8.93

2.5

2.8

139.08

236.48

e6/l

0.96

127

753

Malignant neoplasm of bone and articular cartilage of other and unspecified sites, including Hilmo

12.87

8.92

1.9

2.1

33.00

173.25

e6/l

1.51

Malignant neoplasm of prostate

251

2.10

8.91

2.8

2.3

83.20

129.98

e6/l

2.42

243

Malignant neoplasm of tonsil, including Hilmo

8.12

8.90

1.7

1.5

1188.89

164.04

e6/l

0.43

Conductive and sensorineural hearing loss

344

1592

1.44

8.90

2.3

2.6

578.19

280.67

e6/l

0.50

337

1542

Conduction disorders

127

563

1.81

8.87

2.2

2.6

154.90

455.38

e6/l

1.09

120

549

Coronary revascularization (ANGIO or CABG)

338

1426

1.44

8.78

2.2

2.8

286.16

323.04

e6/l

0.11

322

1389

Gout, strict definition

452

2.00

8.78

2.2

168.23

297.13

e6/l

0.32

434

Malignant neoplasm of bone and articular cartilage

14.49

8.76

1.9

2.4

30.36

209.80

e6/l

—

Fibromyalgia

215

2.48

8.69

2.2

2.7

253.46

117.73

e6/l

1.17

209

Soft tissue disorders

438

1625

1.38

8.68

2.6

2.7

249.71

346.47

e6/l

0.46

423

1585

Substance use, excluding alcohol

101

531

1.91

8.63

2.7

169.84

267.69

e6/l

0.59

519

Major coronary heart disease event

360

1521

1.42

8.53

2.1

2.8

275.45

312.28

e6/l

0.12

343

1481

Other headache syndromes

180

1116

1.61

8.51

2.1

2.8

327.03

192.58

e6/l

0.44

172

1087

Migraine

215

1078

1.55

8.42

2.1

2.7

173.89

198.73

e6/l

0.26

210

1058

Use of peginterferon beta-1a

15.66

8.37

3.1

1.6

147.00

221.33

e6/l

—

Rheumatism, unspecified

307

2.20

8.34

1.7

2.5

212.56

432.06

e6/l

0.46

295

Other dorsopathies, not elsewhere classified

428

1619

1.37

8.26

2.5

2.6

196.23

350.05

e6/l

0.91

408

1585

Other diseases of anus and rectum

130

746

1.74

8.26

2.2

2.4

865.69

357.45

e6/l

0.40

130

717

Misadventures to patients during surgical and medical care

356

2.09

8.15

2.3

105.79

127.09

e6/l

0.50

344

Malignant neoplasm of heart, mediastinum and pleura

11.95

8.11

2.1

3.5

95.14

176.75

e6/l

0.63

Weight loss

237

2.34

7.94

2.9

2.2

1461.29

138.70

e6/l

0.49

226

Emergency coronary revascularization (for ACS)

359

1552

1.40

7.92

2.1

2.7

274.45

322.76

e6/l

0.16

343

1509

Dorsopathies

436

1625

1.36

7.87

2.5

2.6

237.02

349.48

e6/l

0.56

417

1591

Abnormal weight loss

220

2.38

7.83

2.9

2.2

1536.13

135.17

e6/l

0.49

210

Sensorineural hearing loss

323

1522

1.42

7.82

2.3

2.6

599.79

286.77

e6/l

0.49

315

1472

Conjunctivitis (acute, non atopic), including avohilmo

444

1992

1.35

7.80

2.8

2.5

317.35

298.14

e6/l

0.06

430

1944

Sleep disorders (combined)

476

1861

1.34

7.76

2.2

2.7

297.02

299.80

e6/l

0.01

458

1816

Scleritis

8.22

7.64

2.4

1.8

146.63

197.05

e6/l

0.44

Other or unspecified immunodeficiency

14.39

7.53

4.3

1.4

357.50

250.56

e6/l

—

COPD

187

977

1.56

7.50

1.9

2.5

267.41

304.26

e6/l

0.09

180

940

Type 2 diabetes, wide definition

342

1550

1.39

7.48

2.4

2.7

289.66

309.58

e6/l

0.06

329

1511

Anxiety (asthma-related co-morbidities)

266

1400

1.45

7.40

2.8

2.6

180.08

268.82

e6/l

0.76

257

1373

Non-allergic asthma (mode), excluding more controls

243

2.25

7.33

1.9

2.6

1596.65

161.71

e6/l

0.54

236

Hypothyroidism, other/unspecified

372

1792

1.37

7.30

2.5

2.6

147.98

351.63

e6/l

2.18

360

1745

Missing teeth due to accident, extraction or parodontitis

271

1699

1.43

7.19

2.9

2.5

512.72

293.53

e6/l

0.35

263

1643

Other forms of systemic lupus erythematosus

8.23

7.19

2.6

2.3

21.20

201.16

e6/l

3.11

Other retinal disorders

268

1430

1.43

6.94

2.2

2.6

297.05

374.25

e6/l

0.20

259

1379

Haemorrhoids and perianal venous thrombosis

140

859

1.62

6.91

2.3

2.5

183.55

354.22

e6/l

0.88

131

827

Disorders of vestibular function (Vertigo)

194

1258

1.51

6.87

2.3

2.5

450.26

307.31

e6/l

0.17

189

1211

Pneumothorax

142

2.63

6.87

3.0

2.3

369.11

139.81

e6/l

0.67

136

Non-allergic asthma (mode)

250

2.19

6.87

1.9

2.5

1596.65

158.87

e6/l

0.55

243

Other diseases of hard tissues of teeth

212

729

1.51

6.82

2.6

2.3

265.73

283.29

e6/l

0.04

204

704

Diseases of arteries, arterioles and capillaries

280

1460

1.41

6.75

2.1

2.6

118.44

378.04

e6/l

2.31

266

1417

Infectious mononucleosis

180

2.40

6.68

3.0

3.2

110.51

158.49

e6/l

1.62

174

Infectious mononucleosis, including avohilmo

180

2.40

6.68

3.0

3.2

110.51

158.49

e6/l

1.62

174

Non-selective monoamine reuptake inhibitors

156

957

1.57

6.66

2.2

2.5

507.17

391.47

e6/l

0.19

149

932

Functional dyspepsia

115

684

1.69

6.62

2.3

2.6

136.98

382.61

e6/l

1.27

110

661

Depression or dysthymia

290

1127

1.41

6.61

2.8

2.5

270.80

427.45

e6/l

0.53

276

1101

Hypothyreosis and Thyroxine purchase for inclusion criteria

378

1855

1.34

6.47

2.5

2.6

147.71

345.99

e6/l

2.21

365

1806

Obesity due to excess calories

210

1445

1.46

6.38

2.5

2.7

190.03

251.59

e6/l

0.43

203

1409

Secondary malignant neoplasm of other and unspecified sites

8.26

6.35

1.4

124.08

138.87

e6/l

0.10

Diverticular disease of intestine

284

1269

1.40

6.34

2.4

2.5

170.26

352.94

e6/l

1.28

276

1231

Diseases of inner ear

223

1485

1.44

6.33

2.3

2.5

402.67

293.71

e6/l

0.15

218

1434

Cholelithiasis, broad definition with cholecystitis

359

1784

1.34

6.33

2.6

162.50

347.61

e6/l

1.72

353

1730

ILD medications: nintedanib

+∞

6.28

1.5

0.0

120.33

—

e6/l

—

Molar incisor enamel hypoplasia, with caries

18.31

6.27

5.3

2.0

162.56

177.60

e6/l

—

Polycystic ovarian syndrome, consortium definition

273

1120

1.40

6.14

2.5

228.64

288.52

e6/l

0.29

264

1096

Other anxiety disorders

191

1102

1.48

6.12

2.5

2.6

199.65

273.80

e6/l

0.47

184

1086

Dentofacial anomalies [including malocclusion]

299

1717

1.36

6.07

2.4

2.7

387.32

209.43

e6/l

0.59

293

1676

Unknown and unspecified causes of morbidity

105

2.78

6.05

3.3

2.5

163.38

157.02

e6/l

0.04

100

Recurrent or chronic depression

171

785

1.51

5.99

2.6

151.84

345.62

e6/l

1.12

164

769

Retinal detachments and breaks

146

946

1.55

5.97

2.3

2.4

442.38

393.03

e6/l

0.07

141

910

Progressive systemic sclerosis

15.74

5.97

2.9

1.5

17.56

117.50

e6/l

—

Injuries to the abdomen, lower back, lumbar spine and pelvis

170

1121

1.50

5.97

2.5

2.6

105.78

387.64

e6/l

2.11

160

1084

Malignant neoplasm of endocrine gland, including Hilmo

123

2.62

5.96

3.1

2.4

104.84

137.73

e6/l

0.79

118

Cholelithiasis

342

1749

1.34

5.95

2.6

166.39

352.96

e6/l

1.68

336

1695

Spirochaetal infections, other/unspecified

229

2.15

5.93

2.0

2.2

280.51

247.58

e6/l

0.07

220

Fracture of lumbar spine and pelvis

553

1.72

5.91

2.5

2.4

80.51

229.93

e6/l

1.20

529

Internal derangement of knee

150

970

1.53

5.90

2.4

2.8

653.12

370.93

e6/l

0.23

145

944

Disorders of vitreous body and globe

216

1437

1.42

5.82

2.6

2.5

415.91

301.92

e6/l

0.26

210

1388

Disorders of the thyroid gland

391

1941

1.31

5.82

2.6

156.02

336.23

e6/l

2.00

379

1890

Malignant neoplasm of endocrine gland

108

2.70

5.75

2.6

2.3

91.59

141.65

e6/l

1.54

103

Irregular menses

188

964

1.47

5.75

2.8

2.6

198.46

296.39

e6/l

0.48

182

949

Disorders of vitreous body

211

1410

1.43

5.74

2.6

2.5

424.91

279.55

e6/l

0.34

205

1362

Crystal arthropathies, rheuma endpoint

5.64

5.70

1.2

2.1

66.13

82.41

e6/l

0.21

Otitis externa, unspecified

287

2.00

5.68

2.7

1262.49

229.73

e6/l

0.45

277

Other chronic obstructive pulmonary disease

171

943

1.49

5.67

1.9

2.5

286.66

311.35

e6/l

0.05

164

907

Unspecified haematuria

177

978

1.48

5.66

2.0

2.4

328.01

486.31

e6/l

0.44

172

942

Disease of hard tissues of teeth, NOS

201

721

1.46

5.65

2.4

2.3

641.28

282.15

e6/l

0.43

196

698

Cystitis

336

1501

1.33

5.64

3.0

2.5

203.39

361.64

e6/l

0.97

327

1456

Other intervertebral disc disorders

334

1495

1.33

5.63

2.4

2.6

302.49

364.99

e6/l

0.19

319

1462

Open wound of lower leg

372

1.86

5.62

1.9

2.7

120.50

396.82

e6/l

1.13

358

Familial hypercholesterolemia

344

1.90

5.61

2.5

2.3

380.69

120.11

e6/l

0.57

330

Other gastritis (incl. Duodenitis)

542

1.70

5.56

2.2

2.5

376.48

573.76

e6/l

0.25

520

Injuries to the wrist and hand

429

2220

1.28

5.54

2.3

2.6

160.42

315.20

e6/l

1.79

420

2159

Chronic periodontitis, including avohilmo

414

2052

1.29

5.52

2.7

2.6

417.70

275.03

e6/l

0.33

403

1995

Any mental disorder

450

1760

1.28

5.52

3.0

2.5

208.34

349.04

e6/l

0.86

433

1718

Gingivitis and periodontal diseases

408

1626

1.30

5.51

2.7

2.5

717.50

226.26

e6/l

1.12

398

1576

Dizziness and giddiness

316

1849

1.33

5.49

2.6

2.5

505.39

286.73

e6/l

0.44

309

1792

Personal history of medical treatment

7.23

5.47

1.5

2.3

241.83

123.76

e6/l

1.26

Malignant neoplasm of thymus, including Hilmo

16.71

5.47

3.0

1.0

26.50

331.60

e6/l

—

Symptoms and signs involving cognition, perception, emotional state and behaviour

404

2101

1.29

5.36

2.7

2.6

482.72

273.28

e6/l

0.54

396

2042

Dislocation, sprain and strain of joints and ligaments at wrist and hand level

126

811

1.56

5.36

2.2

2.9

179.87

243.09

e6/l

0.47

126

790

Periodontitis

413

2053

1.28

5.35

2.7

2.6

420.05

274.75

e6/l

0.33

402

1996

Hypothyroidism, strict autoimmune, 3 medication purchases required

333

1699

1.32

5.32

2.4

2.5

145.73

314.02

e6/l

1.75

322

1653

External causes of morbidity and mortality

265

967

1.38

5.30

2.5

226.83

277.47

e6/l

0.16

253

946

Nonpyogenic thrombosis of intracranial venous system

6.85

5.29

3.1

1.8

98.67

139.28

e6/l

0.40

Other diseases of liver

483

1.73

5.28

2.9

2.7

134.98

254.70

e6/l

0.68

466

Malignant neoplasm of eye and adnexa, including Hilmo

6.77

5.27

2.6

1.2

211.50

195.11

e6/l

0.05

Other arrhythmias

248

1352

1.37

5.24

2.2

2.8

645.10

310.31

e6/l

0.49

240

1324

STROKE

226

1095

1.39

5.14

2.4

2.8

208.49

324.62

e6/l

0.59

218

1072

Other and unspecified effects of external causes

118

758

1.56

5.09

2.6

2.7

208.52

216.62

e6/l

0.04

112

738

Malignant neoplasm of thyroid gland

2.67

4.91

2.4

2.2

90.88

145.45

e6/l

1.43

Malignant neoplasm of thyroid gland, including Hilmo

106

2.56

4.87

3.1

2.3

97.44

140.92

e6/l

1.04

101

446

1.70

4.87

2.1

1.9

106.09

297.30

e6/l

0.67

421

Psychiatric diseases

402

1579

1.28

4.84

2.8

2.5

240.24

366.45

e6/l

0.61

386

1542

Acquired pure red cell aplasia [erythroblastopenia]

11.94

4.84

2.8

1.4

76.50

96.86

e6/l

—

Insulin, combination of fast acting with intermediate-acting or long-acting

247

1665

1.35

4.83

2.5

2.6

603.04

289.78

e6/l

0.44

241

1612

Other diseases of stomach and duodenum

137

2.35

4.83

2.5

2.3

92.22

126.73

e6/l

0.66

129

Chronic myeloid leukaemia, including Hilmo

9.20

4.81

6.6

1.3

163.11

129.80

e6/l

—

Coxarthrosis [arthrosis of hip](FG)

190

931

1.41

4.66

2.4

2.6

516.25

436.70

e6/l

0.07

184

906

Emphysema

159

2.21

4.62

1.7

2.2

111.11

146.01

e6/l

0.47

150

Outcome of delivery

243

0.30

4.57

2.3

2.6

131.25

283.15

e6/l

0.72

238

Non-small cell lung cancer, adenocarcinoma, helper endpoint

141

2.28

4.54

1.3

1.9

117.38

138.03

e6/l

0.24

132

Leiomyosarcoma, including Hilmo

10.20

4.54

3.1

1.3

133.13

127.50

e6/l

—

Autoimmune hepatitis

10.19

4.54

1.8

2.1

51.62

125.75

e6/l

—

Malignant melanoma of skin, including Hilmo

193

2.08

4.54

2.5

2.0

204.45

138.29

e6/l

0.36

185

Melanocytic naevi, other sites/unspecified

207

2.04

4.52

2.0

2.5

131.19

281.50

e6/l

0.63

201

Lung transplant status

6.87

4.50

2.4

2.1

125.20

192.67

e6/l

—

Lung transplantation

6.87

4.50

2.4

2.1

125.20

192.67

e6/l

—

Primary biliary cholangitis, wide definition

5.27

4.46

1.8

2.0

101.33

151.43

e6/l

0.46

Other external causes of accidental injury

331

1284

1.29

4.45

2.3

2.7

314.51

333.67

e6/l

0.04

316

1257

Congenital malformations, deformations and chromosomal abnormalities

236

1676

1.34

4.44

2.8

2.7

276.49

250.18

e6/l

0.09

231

1635

Rosacea

321

1.81

4.44

2.5

211.21

219.10

e6/l

0.03

308

Benign neoplasm of colon, rectum, anus and anal canal

254

1625

1.32

4.40

2.4

2.5

149.05

354.63

e6/l

1.81

246

1571

Diseases of salivary glands

132

899

1.47

4.39

2.9

2.6

144.09

316.54

e6/l

1.16

126

872

Injury, poisoning and certain other consequences of external causes

216

789

1.37

4.39

2.4

2.5

257.73

286.82

e6/l

0.07

205

769

Coxibs

111

373

1.56

4.38

2.5

2.7

160.67

418.07

e6/l

0.63

105

364

Injuries to the head

458

2201

1.24

4.34

2.4

2.6

224.59

316.03

e6/l

0.55

444

2147

Exclusions for E4_PCOS_CONSORTIUM

273

1297

1.31

4.34

2.6

202.22

291.81

e6/l

0.55

263

1266

Malignant neoplasm of eye and adnexa

9.08

4.30

2.5

1.2

264.88

307.56

e6/l

—

Oxicams

328

1.61

4.26

2.3

2.6

397.02

446.55

e6/l

0.05

319

Diseases of male genital organs

207

760

1.37

4.22

2.7

134.01

338.08

e6/l

1.44

198

742

Spondylosis

214

1242

1.35

4.19

2.5

2.6

261.57

385.78

e6/l

0.36

207

1210

Unspecified fall

202

1468

1.35

4.17

2.2

2.6

202.37

334.70

e6/l

0.76

196

1423

Insulin medication

247

1560

1.32

4.13

2.5

2.7

603.04

280.45

e6/l

0.46

241

1518

Spinal stenosis

199

1079

1.36

4.11

2.1

2.5

205.88

445.97

e6/l

1.14

189

1050

Meningitis, viral

8.31

4.10

2.0

1.7

224.00

209.80

e6/l

—

Explicit fungal Sepsis

8.20

4.09

1.9

1.5

294.63

124.30

e6/l

—

Explicit fungal Sepsis, including avohilmo

8.20

4.09

1.9

1.5

294.63

124.30

e6/l

—

Other leukaemias of specified cell type

10.68

4.08

7.7

1.4

190.14

131.43

e6/l

—

Injuries to the hip and thigh

187

1229

1.37

4.07

2.8

2.4

176.86

387.94

e6/l

1.18

181

1185

Thyroiditis, ILD-related definition

203

1.98

4.00

1.6

2.5

137.27

256.96

e6/l

0.44

193

Any dementia, excluding more controls

691

0.59

3.92

2.5

2.1

132.18

475.74

e6/l

1.31

662

Atopic dermatitis

223

1343

1.32

3.90

2.8

2.7

143.92

259.71

e6/l

1.25

217

1312

Disorders of puberty, all

5.32

3.84

3.6

2.4

167.50

124.63

e6/l

—

Benign neoplasm: Thymus

12.75

3.82

2.5

1.2

23.83

177.60

e6/l

—

Abnormal findings in cerebrospinal fluid

12.56

3.80

2.2

138.50

145.40

e6/l

—

Malignant neoplasm of thymus

12.48

3.80

2.3

1.0

23.67

331.60

e6/l

—

malignant neoplasm of female genital organs, including Hilmo

224

1.88

3.78

2.3

2.2

99.48

180.19

e6/l

0.89

211

Injuries to the knee and lower leg

480

2144

1.21

3.76

2.3

2.6

243.17

300.35

e6/l

0.19

466

2091

Accidents

324

1284

1.27

3.75

2.4

2.7

318.84

333.67

e6/l

0.03

311

1257

Other inflammation of eyelid

354

1.70

3.75

2.6

168.92

183.17

e6/l

0.06

340

Congenital malformations, deformations and chromosomal abnormalities, including avohilmo

254

1797

1.29

3.74

2.8

2.7

266.98

239.35

e6/l

0.10

247

1755

Benign neoplasm: Colon

213

1518

1.32

3.73

2.5

144.23

361.49

e6/l

1.81

205

1467

Malignant melanoma of skin

154

2.08

3.71

2.8

2.1

94.25

139.53

e6/l

1.11

146

Failed induction of labour

128

2.20

3.70

3.2

169.14

352.07

e6/l

0.46

128

Other condition

371

1.68

3.69

2.6

568.85

145.25

e6/l

0.53

357

Renal tubulo-interstitial disorders in diseases classified elsewhere

5.74

3.68

1.8

1.7

25.78

157.69

e6/l

—

Left ventricular outflow tract obstruction (LVOTO), broad definition

246

1.84

3.65

2.5

2.8

236.82

401.58

e6/l

0.39

240

Any dementia

725

0.62

3.64

2.4

2.0

126.93

402.17

e6/l

1.05

689

Other disorders of eyelid

164

1135

1.37

3.63

2.4

539.69

298.40

e6/l

0.25

155

1091

Gonarthrosis [arthrosis of knee](FG)

252

1121

1.29

3.61

2.5

2.8

551.13

406.98

e6/l

0.17

238

1095

Fall on same level

464

2047

1.21

3.59

2.4

2.7

130.82

311.47

e6/l

2.57

449

2000

Felty syndrome

8.01

3.59

2.4

1.6

57.14

189.33

e6/l

—

Hyperplasia of prostate

144

576

1.41

3.57

2.7

2.6

113.07

340.37

e6/l

1.19

136

558

Primary biliary cholangitis (PBC)

4.80

3.56

2.1

1.9

100.60

152.00

e6/l

—

Lumbar disc prolapse

249

1436

1.29

3.53

2.4

2.7

353.11

357.55

e6/l

0.01

238

1405

Other nutritional deficiencies

269

1939

1.27

3.52

2.4

2.6

189.76

293.98

e6/l

0.90

259

1892

Falls/tendency to fall

430

1772

1.22

3.51

2.3

2.7

186.44

315.61

e6/l

0.83

416

1735

Leiomyosarcoma

10.18

3.51

3.5

1.3

155.00

108.00

e6/l

—

Exposure to other specified factors

327

2264

1.24

3.51

2.5

2.6

217.78

296.84

e6/l

0.41

313

2210

Sciatica+with lumbago

199

1338

1.32

3.49

2.5

2.7

150.99

368.72

e6/l

1.66

194

1308

Presence of cardiac and vascular implants and grafts

150

799

1.38

3.49

1.8

2.2

122.71

325.78

e6/l

1.59

140

765

Selective serotonin reuptake inhibitors

389

1650

1.23

3.48

2.7

2.5

203.50

343.50

e6/l

0.96

370

1616

Degeneration of macula and posterior pole

176

1013

1.34

3.43

2.2

2.4

130.32

408.25

e6/l

1.61

171

973

Seborrhoeic keratosis

649

1.48

3.41

2.2

2.4

756.06

380.54

e6/l

0.30

621

Aortic valve malfunction, age under 60 years

231

1.83

3.37

2.6

2.8

235.64

407.42

e6/l

0.38

225

Hypertensive heart and/or renal disease

489

1.48

3.35

1.9

2.6

358.58

442.07

e6/l

0.10

469

Nail disorders

210

1.87

3.34

2.4

2.6

99.33

141.69

e6/l

1.10

204

Arthrosis

255

1093

1.28

3.34

2.2

2.8

256.84

379.12

e6/l

0.41

244

1065

COPD, hospital admissions

170

1070

1.34

3.33

1.9

2.4

286.66

463.76

e6/l

0.46

164

1029

Disorders of lipoprotein metabolism and other lipidaemias

307

1497

1.25

3.32

2.5

2.7

368.93

299.14

e6/l

0.18

296

1458

Malignant neoplasm of penis, including Hilmo

8.75

3.28

3.0

1.3

54.83

189.43

e6/l

—

Triptan medication for migraine, min. 3 purchases

213

1228

1.30

3.28

2.3

2.7

154.86

283.92

e6/l

1.24

207

1205

Speech therapy

672

1.46

3.26

2.1

2.6

111.83

354.17

e6/l

1.33

653

COPD, early/later onset

171

1078

1.33

3.24

1.9

2.4

286.66

460.01

e6/l

0.45

164

1038

Hypoplasia of dental enamel

6.43

3.18

6.4

2.9

104.29

210.00

e6/l

—

Statin medication

192

1404

0.77

3.15

2.8

2.7

284.06

241.14

e6/l

0.11

186

1377

Other arthrosis

190

974

1.31

3.08

1.9

2.8

250.85

382.76

e6/l

0.38

183

947

Pacemaker

129

872

1.38

3.08

2.0

2.3

157.93

408.28

e6/l

1.17

123

833

Disorders of refraction and accommodation

110

777

1.41

3.08

3.0

2.8

158.17

235.99

e6/l

0.68

110

753

Other and unspecified rosacea

231

1.78

3.07

2.6

2.5

250.71

245.57

e6/l

0.01

223

Cirrhosis, broad definition used in the article https://doi.org/10.1101/594523

391

1.59

3.06

1.5

2.4

101.63

132.93

e6/l

0.74

378

Dependence on enabling machines and devices, not elsewhere classified

5.05

3.05

2.6

2.0

48.88

119.13

e6/l

—

Otitis externa

626

1.46

3.01

2.6

2.7

835.48

228.47

e6/l

0.41

606

Hypertensive Heart Disease

453

1.48

2.99

1.7

2.5

379.41

455.47

e6/l

0.08

433

Malignant neoplasm of other and unspecified major salivary glands, including Hilmo

10.14

2.99

2.4

1.6

72.00

122.40

e6/l

—

Injuries to the thorax

176

1350

1.30

2.97

2.6

154.34

357.81

e6/l

1.58

170

1303

Cholecystectomy

264

1807

1.24

2.93

2.5

166.68

343.42

e6/l

1.56

259

1750

Dementia

857

0.69

2.90

2.4

2.1

433.29

407.56

e6/l

0.03

819

Other specified congenital malformation syndromes affecting multiple systems

3.74

2.88

4.7

2.8

262.20

173.59

e6/l

—

Fracture of foot, except ankle

690

1.42

2.88

2.6

2.9

124.34

189.56

e6/l

0.88

668

Other chronic obstructive pulmonary disease, including avohilmo

203

1307

1.28

2.85

1.9

2.5

258.71

417.22

e6/l

0.51

195

1261

Disorders of puberty

4.49

2.80

2.3

2.2

144.38

119.72

e6/l

—

Coxarthrosis

173

856

1.31

2.79

2.5

2.7

536.49

445.24

e6/l

0.08

168

830

Other shoulder lesions

231

1.74

2.79

2.5

2.7

237.15

124.25

e6/l

0.49

224

Cardiomyopathy

377

1.57

2.78

2.4

2.7

1457.89

309.14

e6/l

0.40

369

3.94

2.78

1.9

2.8

186.33

149.83

e6/l

—

Other peripheral vertigo

202

1.79

2.76

1.9

2.2

1889.06

272.20

e6/l

0.44

192

Other and unspecified psoriasis

159

1.90

2.75

2.5

2.2

207.07

144.22

e6/l

0.33

153

Ovarian cyst

121

503

1.38

2.73

2.4

214.88

382.96

e6/l

0.47

116

494

Congenital malformations of cardiac chambers and connections

6.13

2.71

1.5

3.8

660.00

116.20

e6/l

—

Isolated growth hormone deficiency

6.11

2.71

5.2

3.2

175.00

192.70

e6/l

—

Cerebrovascular diseases

279

1580

1.23

2.70

2.3

2.5

351.30

337.20

e6/l

0.03

269

1528

Hyphaema and other vascular disorders of iris and ciliary body

3.48

2.69

3.1

1.9

112.40

150.90

e6/l

—

Hernia

355

1972

1.20

2.68

2.7

2.6

109.66

311.38

e6/l

3.45

345

1918

Coronary atherosclerosis

235

1188

1.25

2.66

2.2

2.7

224.00

358.96

e6/l

0.52

224

1154

Acetic acid derivatives and related substances

100

364

1.42

2.66

2.2

2.7

199.29

423.98

e6/l

0.50

355

Meniscus derangement

192

1000

1.28

2.63

2.4

2.8

269.31

377.19

e6/l

0.27

183

972

Procreative management

128

789

1.34

2.57

2.3

2.7

490.34

241.67

e6/l

0.68

128

770

Ovarian dysfunction, other/unspecified

5.56

2.56

2.0

2.1

170.00

212.09

e6/l

—

Malignant neoplasm of other and unspecified urinary organs, including Hilmo

7.24

2.56

1.2

1.4

103.00

164.00

e6/l

—

Malignant neoplasm of ureter, including Hilmo

7.23

2.56

2.2

1.3

3043.00

213.86

e6/l

—

Social disorders starting during childhood or adolescence

7.23

2.55

4.2

3.0

173.80

85.57

e6/l

—

Collapsed vertebra, not elsewhere classified

5.54

2.55

2.8

1.4

54.00

36.00

e6/l

—

Intracranial injury

220

1659

1.24

2.45

2.4

2.7

148.19

348.51

e6/l

1.94

213

1613

Injuries to the ankle and foot

280

1981

1.21

2.45

2.4

2.7

298.41

239.58

e6/l

0.17

271

1934

Anomalies of dental arch relationship, including avohilmo

462

1.45

2.44

2.8

131.47

210.40

e6/l

0.73

449

Schizophrenia

429

0.53

2.41

2.5

2.7

144.52

290.89

e6/l

0.77

418

Malignant neoplasm of bone and articular cartilage of limbs, including Hilmo

5.06

2.41

1.2

2.0

155.17

156.83

e6/l

—

Persistent delusional disorders

176

0.34

2.39

2.8

2.7

92.50

360.68

e6/l

—

170

Malignant neoplasm of nasal cavity and middle ear, including Hilmo

6.34

2.38

2.8

1.4

34.00

192.13

e6/l

—

Obesity and other hyperalimentation

245

1892

1.22

2.38

2.4

2.6

192.27

253.03

e6/l

0.52

236

1845

Follicular adenocarcinoma of thyroid gland, including Hilmo

6.31

2.38

1.4

1.3

102.60

241.63

e6/l

—

Use of antiglaucoma preparations and miotics

146

1.86

2.37

2.3

1.9

101.15

137.83

e6/l

0.54

136

Complications associated with artificial fertilization

2.85

2.35

2.2

2.6

121.18

189.28

e6/l

0.79

Peritonsillar abscess

517

1.43

2.34

2.5

3.0

175.62

196.43

e6/l

0.11

501

Carpal tunnel syndrome

222

1567

1.23

2.32

2.3

2.6

246.49

274.54

e6/l

0.12

213

1527

COPD related to multimorbidity

139

907

1.30

2.29

1.9

2.3

323.94

484.78

e6/l

0.33

133

871

Unspecified jaundice

2.13

2.28

2.0

119.89

146.35

e6/l

0.39

Schizoaffective disorder

185

0.38

2.27

2.7

137.71

161.52

e6/l

—

180

Obesity

243

1888

1.21

2.27

2.4

2.6

193.62

253.48

e6/l

0.51

234

1841

Malignant neoplasm of pancreas, including Hilmo

2.03

2.25

2.4

1.9

96.75

130.02

e6/l

0.83

Perforation of tympanic membrane

239

1.64

2.25

2.6

220.72

154.38

e6/l

0.25

230

COPD, hospital admissions 1, only main diagnosis

117

764

1.32

2.19

2.0

2.3

377.14

482.08

e6/l

0.17

112

732

Other sexually transmitted chlamydial diseases, including avohilmo

218

1.66

2.18

3.1

3.2

185.83

334.02

e6/l

0.42

212

Other and unspecified myopathies

203

1.68

2.17

2.5

2.2

150.71

158.08

e6/l

0.08

193

Onycholysis

4.36

2.16

3.0

1.4

50.83

213.86

e6/l

—

Unequal limb length (acquired)

4.34

2.16

2.7

2.0

134.17

204.00

e6/l

—

Malignant neoplasm of testis, including Hilmo

3.02

2.15

3.7

2.5

72.56

144.13

e6/l

—

Chronic periodontitis, complicated

216

1730

1.22

2.14

3.1

2.5

681.12

274.40

e6/l

0.55

208

1679

Polypectomy (DHB20)

152

0.33

2.13

1.0

2.3

129.60

144.65

e6/l

—

147

Short stature, not elsewhere classified

3.00

2.11

2.9

264.44

268.25

e6/l

—

HSIL lesion of the vagina

3.23

2.10

1.5

1.9

175.50

202.12

e6/l

—

Dementia, including avohilmo

102

920

0.75

2.10

2.6

2.1

383.99

400.53

e6/l

0.02

882

Malignant neoplasm of corpus uteri, including Hilmo

102

1.97

2.10

2.9

2.0

102.65

219.06

e6/l

0.52

Pure hypercholesterolaemia

264

1400

1.20

2.09

2.5

2.6

266.20

304.02

e6/l

0.11

253

1362

Dermatophytosis, including avohilmo

242

1976

1.20

2.08

2.2

2.6

452.65

291.92

e6/l

0.24

234

1925

Stenosis and insufficiency of lacrimal passages

198

1.67

2.08

2.9

2.4

113.70

243.87

e6/l

0.48

188

Carcinoma in situ of vagina

5.08

2.08

1.2

1.4

164.80

295.90

e6/l

—

Social disorders starting during childhood or adolecense, excluding more controls

5.06

2.08

4.2

1.8

173.80

128.60

e6/l

—

Malignant neoplasm of base of tongue, including Hilmo

5.06

2.08

3.2

1.3

62.60

195.70

e6/l

—

Lack of expected normal physiological development

3.62

2.07

3.7

1.5

190.00

196.35

e6/l

—

Autoimmune hyperthyroidism

2.03

2.05

2.7

2.6

179.56

426.68

e6/l

0.39

Open wound of head

208

1607

1.22

2.05

2.3

2.7

265.81

350.45

e6/l

0.25

199

1560

Fracture of rib(s), sternum and thoracic spine

112

858

1.31

2.05

2.4

2.6

162.59

350.02

e6/l

0.96

107

825

Acquired absence of limb

4.05

2.04

2.5

2.0

218.83

126.80

e6/l

—

Molar incisor enamel hypoplasia

2.24

2.00

4.1

2.3

175.07

218.05

e6/l

0.39

Other and unspecified nonorganic psychotic disorders

513

0.62

1.96

2.4

2.7

153.34

268.74

e6/l

0.69

502

Orchitis and epididymitis

225

1.60

1.96

1.9

2.6

101.97

276.87

e6/l

0.53

216

Mixed conductive and sensorineural hearing loss

297

1.52

1.94

2.5

2.4

94.24

120.59

e6/l

0.62

283

Crossbite

137

1.75

1.92

2.5

2.7

198.69

167.98

e6/l

0.24

132

Disorders of tooth development and eruption

307

1.46

1.92

3.4

2.5

135.60

155.51

e6/l

0.36

298

Other otitis externa (chronic)

150

1.74

1.90

2.5

2.3

2566.92

156.63

e6/l

0.48

144

Other congenital malformations of nervous system

3.57

1.84

2.5

2.0

176.67

232.41

e6/l

—

Right ventricular outflow tract obstruction

4.22

1.83

2.2

3.2

366.00

133.75

e6/l

—

malignant neoplasm of female genital organs

201

1.61

1.83

2.3

2.2

96.27

185.29

e6/l

0.88

189

Insulin, intermediate and long-acting

197

1579

1.20

1.81

2.5

2.6

734.76

283.57

e6/l

0.54

192

1527

Malignant neoplasm of testis

2.78

1.79

3.1

2.5

81.63

147.72

e6/l

—

Malignant neoplasm of corpus uteri

1.96

1.79

2.4

1.9

118.41

232.32

e6/l

0.40

Specific developmental disorder of motor function

3.45

1.79

3.3

3.2

200.83

200.00

e6/l

—

Spinal osteochondrosis

3.36

1.75

1.5

2.2

135.67

108.50

e6/l

—

Varicose veins

203

1279

1.20

1.74

2.3

2.5

231.78

363.06

e6/l

0.44

196

1241

Other and unspecified disorders of autonomic nervous system

3.93

1.73

1.4

1.7

221.60

192.62

e6/l

—

Vascular syndromes of brain in cerebrovascular disorders

2.01

1.69

5.4

1.7

1671.80

116.04

e6/l

0.46

Appendectomy

237

1918

1.18

1.69

2.6

2.7

174.36

298.52

e6/l

1.16

232

1871

Mental and behavioural disorders due to alcohol

132

1552

0.81

1.67

2.4

2.7

155.74

371.91

e6/l

1.90

125

1511

Type 2 diabetes

367

1861

1.14

1.65

2.4

2.7

319.51

280.29

e6/l

0.12

351

1821

Chondropathies

384

1.41

1.65

3.0

2.6

165.57

302.25

e6/l

0.60

374

Gonarthrosis

209

992

1.19

1.61

2.5

2.8

277.11

401.68

e6/l

0.34

197

964

Hypermetropia

158

1.65

1.61

2.2

2.3

123.96

156.41

e6/l

0.38

153

Bullous disorders

113

1.78

1.60

1.8

2.0

168.55

125.00

e6/l

0.32

108

Premenstrual syndrome

2.52

1.60

1.9

2.1

99.63

218.31

e6/l

—

Hyperhidrosis

2.51

1.59

2.1

2.5

159.63

120.19

e6/l

—

Excessive attrition of teeth

226

1907

1.17

1.59

2.5

2.7

224.55

274.32

e6/l

0.25

221

1861

Routine general health check-up of defined subpopulation

2.70

1.58

1.4

2.0

174.71

102.46

e6/l

—

Motor disorders

3.00

1.57

3.3

3.9

200.83

197.50

e6/l

—

Use of eye-antiallergens (taken as indicator of allergic/atopic conjunctivitis)

188

1513

1.19

1.57

2.4

2.6

124.70

259.73

e6/l

1.79

183

1477

Spermatocele

191

1.58

1.56

2.4

2.6

95.70

125.65

e6/l

0.41

182

Ischaemic heart disease, wide definition

282

1502

1.16

1.55

2.1

2.7

187.99

328.36

e6/l

0.72

269

1460

Pleural plaque without asbestos

2.04

1.54

2.8

1.6

300.15

112.68

e6/l

0.35

Maternal infectious and parasitic diseases classifiable elsewhere but complicating pregnancy, childbirth and the puerperium

2.44

1.54

5.0

4.2

209.75

164.55

e6/l

—

Arnold-Chiari syndrome

3.36

1.53

2.6

1.5

196.00

242.73

e6/l

—

Glaucoma

193

1383

1.19

1.52

2.4

616.74

347.38

e6/l

0.30

188

1333

Other hammer toe(s) (acquired)

331

1.40

1.52

2.5

2.4

110.71

527.28

e6/l

1.09

317

Chalazion

282

1.46

1.51

2.5

2.6

206.85

212.83

e6/l

0.02

273

Artificial joint operation, meniscal resection

332

1863

1.14

1.51

2.1

2.6

202.20

332.04

e6/l

0.66

319

1810

Family history of other specific disorders

2.88

1.51

1.7

2.3

266.83

195.00

e6/l

—

Diabetes, varying definitions

379

1946

1.13

1.48

2.5

2.7

313.47

274.01

e6/l

0.12

361

1905

Myopia

317

1.42

1.47

3.1

2.8

193.47

345.99

e6/l

0.54

310

Dental pulpitis, including avohilmo

353

1996

1.13

1.47

2.5

2.6

168.45

285.06

e6/l

1.27

346

1947

Hypoplasia of dental enamel , including avohilmo

2.07

1.46

4.6

2.4

152.58

219.79

e6/l

0.71

Fracture of lower leg, including ankle

197

1644

1.18

1.46

2.6

2.7

404.98

332.52

e6/l

0.10

190

1602

LSIL lesion of the vagina

2.52

1.45

1.9

2.6

116.29

189.29

e6/l

—

Disorders of male genital organs in diseases classified elsewhere

3.17

1.44

1.2

1.8

233.00

145.81

e6/l

—

Malignant neoplasm of other and ill-defined sites, including Hilmo

3.14

1.44

1.4

1.8

47.00

180.63

e6/l

—

Tooth eruption problems

324

1.40

1.43

3.1

2.9

164.43

174.16

e6/l

0.15

317

Diabetes mellitus

380

1949

1.13

1.43

2.5

2.7

311.66

274.87

e6/l

0.11

362

1908

Lichen planus

311

1.42

2.2

2.5

196.18

216.70

e6/l

0.07

296

Acne, including avohilmo

451

1.31

1.42

2.4

2.9

159.70

171.38

e6/l

0.23

444

HSIL lesion of the cervix uteri, vagina or vulva

499

1.32

1.42

2.9

2.7

139.36

220.01

e6/l

0.79

492

Acne

236

1.48

1.40

2.6

3.0

139.74

160.93

e6/l

0.29

230

Delayed milestone in childhood

2.71

1.40

4.2

3.4

303.83

313.00

e6/l

—

All dysplastic lesions of the cervix uteri

648

1.28

1.39

3.5

2.6

199.48

199.72

e6/l

0.00

636

Disorders of psychological development

243

1.45

1.39

2.7

2.9

866.53

164.22

e6/l

0.55

237

Male infertility

1.78

1.39

5.1

3.0

110.47

516.46

e6/l

0.56

Acne vulgaris

182

1.54

1.36

2.6

3.1

131.00

168.23

e6/l

0.53

177

HSIL lesion of the cervix uteri

452

1.33

1.34

3.0

2.7

130.27

230.45

e6/l

0.95

446

Ankyloglossia

2.50

1.30

4.3

2.9

177.83

196.63

e6/l

—

Embedded teeth, including avohilmo

209

1.49

1.30

2.4

3.1

163.94

151.71

e6/l

0.17

202

Artificial opening status

106

1.70

1.29

2.1

128.00

131.42

e6/l

0.03

100

Mental and behavioural disorders due to alcohol, excluding acute intoxication

114

1371

0.82

1.29

2.4

2.7

160.29

317.16

e6/l

1.23

107

1331

Gilbert syndrome

2.81

1.29

2.0

1.6

111.80

199.83

e6/l

—

Primary hyperparathyroidism

251

1.44

1.28

2.5

115.89

226.92

e6/l

0.53

240

Other appendicitis

218

1.47

1.28

2.7

2.4

106.16

262.90

e6/l

0.70

209

Embedded and impacted teeth

591

1.25

1.26

2.9

2.8

152.00

277.46

e6/l

0.98

581

Excessive earwax

227

1794

1.15

1.24

2.3

2.6

281.43

332.88

e6/l

0.16

220

1736

Benign neoplasm: Rectum

476

1.30

1.23

1.8

2.4

211.05

161.34

e6/l

0.21

455

Substance abuse, excluding more controls

194

1399

1.16

1.22

2.5

166.40

392.76

e6/l

1.76

183

1368

Migraine, single triptan purchase ok & required. ICD-code if available is included

272

1625

1.13

1.22

2.6

2.7

182.41

265.33

e6/l

0.86

265

1590

Triptan medication for migraine, single purchase ok

272

1625

1.13

1.22

2.6

2.7

182.41

265.33

e6/l

0.86

265

1590

Other disorders of bone density and structure

2.05

1.22

3.1

2.0

213.90

159.39

e6/l

—

Striking against or struck by other objects

120

996

1.20

1.21

2.0

2.9

404.30

175.47

e6/l

0.51

112

970

Dermatitis due to ingested food

1.95

1.19

2.5

2.6

203.27

245.02

e6/l

0.38

All dysplastic lesions of the cervix uteri, vagina or vulva

737

1.23

1.18

3.4

2.7

203.14

187.10

e6/l

0.08

723

Myocardial infarction

164

979

1.17

1.16

2.0

2.7

121.66

361.11

e6/l

1.61

153

949

171

1724

0.86

1.16

2.4

2.6

156.15

349.53

e6/l

1.90

161

1680

Ehlers-Danlos syndrome

2.52

1.15

1.0

3.1

204.40

196.00

e6/l

—

Dementia due to Parkinsons disease, excluding more controls

0.00

1.14

0.0

2.4

—

63.61

—

Type 2 diabetes, definitions combined

345

1804

1.11

1.13

2.4

2.7

220.71

282.97

e6/l

0.29

330

1764

Alcohol use disorder, ICD-based

107

1284

0.83

1.12

2.5

2.8

160.70

268.30

e6/l

0.81

100

1248

Lichen planus, including avohilmo

502

1.28

1.11

2.5

2.4

170.63

366.62

e6/l

0.67

484

Vestibular neuronitis

209

1.44

1.10

1.7

2.5

128.77

272.65

e6/l

0.60

202

Other benign neoplasms of connective and other soft tissue

243

1.40

1.09

2.1

2.5

122.59

252.54

e6/l

0.62

234

Other and unspecified glaucoma

136

1.55

1.08

1.6

2.0

80.57

145.33

e6/l

1.14

129

Conductive hearing loss, unspecified

202

1.44

1.07

2.1

2.5

215.76

145.40

e6/l

0.19

193

Torticollis

2.13

1.05

1.7

2.4

147.29

139.67

e6/l

—

Other menopausal disorders

401

0.78

1.05

4.1

2.4

651.84

442.74

e6/l

0.17

395

Allergic conjunctivitis

196

1654

1.14

1.04

2.4

2.6

153.74

269.85

e6/l

1.17

190

1616

Lesion of sciatic nerve

1.74

1.02

1.6

54.00

117.01

e6/l

1.72

Tinnitus

643

1.23

1.02

2.6

2.7

1045.66

245.20

e6/l

0.41

618

Viral haemorrhagic fevers, not elsewhere classified/unspecified, including avohilmo

404

0.72

1.01

3.9

2.6

250.21

287.68

e6/l

0.09

389

Impacted teeth

444

1.26

1.01

3.1

2.7

155.31

185.49

e6/l

0.57

435

Type 2 diabetes, strict (exclude DM1)

346

1824

1.10

1.00

2.3

2.7

219.26

282.19

e6/l

0.30

331

1783

Phakomatoses, not elsewhere classified

2.19

0.98

2.2

2.0

131.40

192.65

e6/l

—

0.00

0.97

0.0

3.3

—

289.41

—

Lichen ruber planus, wide definition including periferal and oral lichen planus

603

1.23

0.96

2.4

2.5

166.88

382.40

e6/l

0.86

581

Suicide or other Intentional self-harm

658

1.22

0.95

2.2

2.8

151.66

248.40

e6/l

0.76

643

Superficial injury of forearm

259

1.35

0.94

2.8

268.91

156.50

e6/l

0.46

250

Congenital malformations of breast

2.23

0.93

2.0

2.4

264.50

165.74

e6/l

—

163

1659

0.88

0.93

2.3

2.7

153.82

358.22

e6/l

1.94

154

1615

Biguanides

291

1940

0.90

0.93

2.3

2.6

277.58

296.53

e6/l

0.06

279

1892

Arthropod-borne viral fevers and viral haemorrhagic fevers, including avohilmo

465

0.75

0.92

3.9

2.6

219.97

267.07

e6/l

0.14

448

Malignant neoplasm of oesophagus

2.15

0.91

1.8

2.2

39.50

170.32

e6/l

—

Pain in thoracic spine

392

1.28

0.91

2.4

2.7

116.50

281.19

e6/l

0.87

386

Glaucoma suspect

117

1001

1.17

0.91

2.5

2.4

189.41

327.28

e6/l

0.66

112

958

Stroke, excluding SAH

201

1288

1.13

0.90

2.1

2.5

320.79

371.26

e6/l

0.10

194

1242

Congenital malformations of breast, including avohilmo

2.08

0.89

2.0

2.8

264.50

161.07

e6/l

—

Alcohol use disorder, Swedish definition

153

1584

0.88

2.4

2.7

161.01

367.35

e6/l

1.83

143

1541

Laparoscopic right hemicolectomy

119

1.52

0.88

3.4

1.7

86.67

130.69

e6/l

1.05

112

Trigger finger

381

0.73

0.87

2.4

2.7

861.79

365.24

e6/l

0.45

371

Oral lichen planus, including avohilmo , including avohilmo

161

1.43

0.86

2.3

2.4

123.74

133.60

e6/l

0.10

156

Thiazolidinediones

287

0.70

0.85

1.6

2.4

132.55

106.75

e6/l

0.39

277

Benign neoplasm: Stomach

221

1.36

0.85

2.2

2.0

185.60

119.38

e6/l

0.25

208

Contact with other sharp object(s)

167

0.60

0.85

1.4

3.0

107.60

156.73

e6/l

—

162

Memory loss

191

0.63

0.84

2.3

1.9

163.33

140.03

e6/l

0.17

183

Monoamine oxidase A inhibitors

265

1.32

0.84

2.8

2.4

132.03

264.78

e6/l

0.46

258

Soft tissue disorders related to use, overuse and pressure

772

1.18

0.82

2.0

2.6

190.89

437.70

e6/l

0.93

748

Fall on same level involving ice and snow

197

1768

1.11

0.79

2.4

2.6

280.48

291.26

e6/l

0.03

188

1722

Injuries to the elbow and forearm

247

1925

1.10

0.76

2.4

2.6

189.13

297.48

e6/l

0.80

240

1874

Additional codes for the location of defect, injury or illness

132

1.44

0.76

5.5

2.3

139.68

154.93

e6/l

0.12

127

Major coronary heart disease event excluding revascularizations

195

1155

1.11

0.75

2.1

2.7

117.16

331.20

e6/l

1.75

184

1120

Type 2 diabetes, definitions combined, including avohilmo

341

1817

1.08

0.75

2.4

2.7

221.33

281.99

e6/l

0.28

326

1778

Family history of other conditions

2.01

0.73

1.0

2.1

2290.80

147.28

e6/l

—

LSIL lesion of the cervix uteri, vagina or vulva

343

1.26

0.72

3.6

2.8

293.16

216.06

e6/l

0.22

336

Peripheral artery disease

133

928

1.13

0.70

1.9

2.4

95.73

451.65

e6/l

2.07

126

894

Endometriosis diagnosis and infertility diagnosis occurring together

256

1.29

0.70

2.2

2.9

107.55

247.43

e6/l

0.78

251

Injuries to the shoulder and upper arm

305

2172

1.08

0.69

2.3

2.6

310.99

308.28

e6/l

0.01

288

2120

Organic, including symptomatic, mental disorders

135

1067

0.89

0.67

2.4

2.3

390.98

402.31

e6/l

0.02

129

1026

Medical abortion

195

955

1.11

0.66

2.6

2.5

265.56

284.41

e6/l

0.06

186

938

Superficial injury of thorax

393

1.22

0.66

3.1

2.5

194.81

288.67

e6/l

0.31

382

Convergence insufficiency and excess

1.79

0.66

1.6

2.2

395.80

158.61

e6/l

—

Injury of other and unspecified intrathoracic organs

162

1.36

0.66

3.4

2.3

117.50

144.67

e6/l

0.58

156

Other and/or unspecified nontoxic goitre

179

0.67

0.66

2.3

2.8

105.08

248.32

e6/l

0.47

171

Dipeptidyl peptidase 4 (DPP-4) inhibitors

190

1351

1.10

0.65

2.4

2.5

136.18

336.70

e6/l

1.85

181

1311

Ectropion of eyelid

1.62

0.65

1.3

1.6

77.40

116.68

e6/l

—

LSIL lesion of the cervix uteri

268

1.27

0.65

4.1

2.9

325.00

237.73

e6/l

0.19

263

Myocardial infarction, strict

146

924

1.12

0.64

2.0

2.7

119.64

367.69

e6/l

1.55

138

895

Allergic colitis

1.73

0.64

3.2

2.9

554.60

216.79

e6/l

—

Benign neoplasm: Rectum, anus and anal canal

534

1.18

0.62

1.8

2.5

208.92

163.53

e6/l

0.19

511

Other/unspecified enthesopathies, not elsewhere classified

208

1.30

0.62

1.7

2.5

170.93

117.72

e6/l

0.69

200

Transient ischemic attack

167

1204

1.10

0.61

2.3

2.4

384.68

372.61

e6/l

0.02

161

1159

Stroke, including SAH

210

1379

1.09

0.61

2.2

2.5

311.88

358.53

e6/l

0.09

202

1333

Hydatidiform mole

0.00

0.60

0.0

2.6

—

134.38

—

Other orthopaedic follow-up care

105

1.43

0.60

1.9

2.2

122.20

176.30

e6/l

0.51

100

Open wound of forearm

227

1.28

0.59

1.8

2.8

121.93

159.68

e6/l

0.54

219

Fall on and from ladder

192

1.30

0.59

3.2

2.3

152.64

136.25

e6/l

0.12

183

Other disorders of penis

246

1.26

0.57

1.7

2.7

145.97

281.10

e6/l

0.42

238

Ischaemic Stroke, excluding all haemorrhages

181

1216

1.10

0.57

2.3

2.4

342.55

376.78

e6/l

0.06

176

1171

Primary gonarthrosis, bilateral

144

1330

0.91

0.56

2.2

2.5

128.54

301.80

e6/l

1.50

137

1286

Other and specified injuries of hip and thigh

1.63

0.55

2.0

1.8

121.33

155.97

e6/l

—

Benign neoplasm of bone and articular cartilage

212

1.28

0.55

2.2

2.8

141.81

154.00

e6/l

0.14

205

Other specified/unspecified hearing loss

206

0.73

0.55

2.5

2.2

117.07

133.46

e6/l

0.13

195

Postpartum haemorrhage due to retained placenta

285

1.23

0.54

2.5

3.0

133.57

266.57

e6/l

0.73

279

Toxic effects of substances chiefly nonmedicinal as to source

294

0.78

0.53

3.4

2.7

162.83

235.42

e6/l

0.35

283

Familial hypercholesterolemia, with ischemic heart disease

214

1.26

0.52

2.8

2.0

99.22

276.08

e6/l

0.54

204

Glucosamine medication

117

1035

0.90

0.51

1.9

2.3

166.47

366.16

e6/l

1.01

111

994

Coxarthrosis, primary

194

1487

1.08

0.50

2.3

2.5

535.73

321.00

e6/l

0.23

189

1431

Fracture of shoulder and upper arm

109

981

1.11

0.48

2.1

2.6

219.75

300.71

e6/l

0.34

103

946

Nonalcoholic fatty liver disease

262

1.22

0.48

2.3

2.6

169.38

242.16

e6/l

0.32

256

Fracture of forearm

180

1493

1.08

0.48

2.4

2.6

182.24

284.86

e6/l

0.65

173

1449

Female infertility

457

1.13

0.47

2.5

2.4

135.62

335.31

e6/l

0.75

451

Infliximab

1.49

0.47

1.1

2.7

143.29

158.11

e6/l

—

Foreign body on external eye

382

1.18

0.47

2.5

2.9

111.56

227.72

e6/l

0.62

369

Brachial plexus disorders

236

1.23

0.46

1.4

2.9

139.86

228.29

e6/l

0.38

231

Transient global amnesia

210

1.24

0.45

2.2

2.1

85.31

133.23

e6/l

0.97

201

Medical treatment for female infertility

512

1.14

0.43

2.3

2.8

128.68

217.94

e6/l

0.96

506

Normal-pressure hydrocephalus

0.64

0.42

3.0

2.0

184.33

117.11

e6/l

—

Personal history of other diseases and conditions

229

1.22

0.42

2.7

2.5

162.32

251.59

e6/l

0.36

224

Carcinoma in situ, bladder

1.43

0.41

2.7

1.9

164.50

127.71

e6/l

—

Motor- or nonmotor-vehicle accident in traffic area

0.00

0.41

0.0

1.7

—

136.47

—

Osteomalacia

0.00

0.41

0.0

1.4

—

242.31

—

Mental and behavioural disorders associated with the puerperium

0.00

0.40

0.0

3.8

—

184.24

—

Patellar tendinitis

1.43

0.39

3.8

2.3

73.20

129.89

e6/l

—

Obstructed labour due to maternal pelvic abnormality

346

0.84

0.39

2.4

2.6

656.21

432.89

e6/l

0.22

336

Mental and behavioural disorders of puerperium, not classified elsewhere

0.00

0.39

0.0

2.5

—

188.79

—

Oesophagitis

115

1.31

0.39

1.8

2.3

142.93

126.75

e6/l

0.10

110

Pregnancy with abortive outcome

198

965

1.07

0.38

2.7

2.5

345.53

283.93

e6/l

0.16

188

947

Infections of genitourinary tract in pregnancy

215

1.21

0.38

2.9

2.8

106.65

255.34

e6/l

0.66

210

Other (not insulin) diabetes medications

312

1924

0.95

0.37

2.4

2.6

243.24

274.96

e6/l

0.12

299

1878

Persons encountering health services for specific procedures, not carried out

190

0.79

0.35

2.1

2.9

171.33

176.33

e6/l

0.04

183

Behavioural syndromes associated with physiological disturbances and physical factors

327

2112

1.05

0.34

2.2

2.7

146.58

302.33

e6/l

2.13

315

2060

Carcinoma in situ of other and unspecified sites

1.34

0.34

2.5

2.1

169.55

124.65

e6/l

0.38

Oedema, proteinuria and hypertensive disorders in pregnancy, childbirth and the puerperium

116

1084

0.93

0.33

2.3

2.6

140.44

268.47

e6/l

1.17

111

1064

Otosclerosis

164

1.22

0.32

2.4

2.1

101.95

145.60

e6/l

0.42

159

Lesion of lateral popliteal nerve

120

1.25

0.30

3.1

2.5

97.27

122.32

e6/l

0.35

115

Pregnancy hypertension

103

991

0.93

0.30

2.4

2.6

138.00

269.19

e6/l

1.07

973

Female infertility, cervical, vaginal, other or unspecified origin

450

1.09

0.30

2.5

2.4

138.92

337.61

e6/l

0.72

444

Injury of eye and orbit

372

1.13

0.29

2.8

2.9

117.71

313.90

e6/l

0.96

360

Polyp of the female genital tract

432

1.09

0.28

2.4

107.00

422.51

e6/l

1.13

424

Puerperal sepsis

312

0.86

0.28

2.5

2.6

115.41

535.19

e6/l

1.10

302

Substance abuse

194

1715

1.05

0.27

2.5

2.6

166.40

348.53

e6/l

1.73

183

1672

Ectopic pregnancy

433

1.11

0.26

2.1

2.8

549.25

349.48

e6/l

0.17

426

Disorders of breast

143

1189

1.06

0.26

2.3

2.6

385.57

263.92

e6/l

0.28

138

1161

Dislocation, sprain and strain of joints and ligaments of knee

207

1786

1.05

0.26

2.1

2.7

169.91

260.30

e6/l

0.96

200

1748

Vascular dementia

153

0.82

0.24

1.4

1.8

60.23

532.05

e6/l

0.96

141

Leiomyoma of uterus

177

945

1.05

0.24

2.6

2.5

230.99

303.41

e6/l

0.29

170

922

Diabetes, insuline treatment (Kela reimbursement), excluding more controls

318

1820

1.04

0.23

2.4

2.7

323.93

283.23

e6/l

0.11

306

1780

Benign lipomatous neoplasm of skin and subcutaneous tissue of limbs

199

1.16

0.23

2.1

2.5

383.96

157.14

e6/l

0.40

193

Glaucoma, exfoliation

199

1.16

0.23

1.9

92.22

292.51

e6/l

0.56

187

Complications predominantly related to the puerperium

650

1.08

0.22

2.8

2.7

168.30

347.14

e6/l

0.77

636

Impingement syndrome of shoulder

670

1.08

0.22

3.0

2.6

130.03

324.73

e6/l

0.99

648

Liveborn infants according to place of birth

0.00

0.21

0.0

4.1

—

235.80

—

Complications specific to multiple gestation

0.00

0.21

0.0

4.9

—

144.80

—

Congenital varicose veins

0.00

0.21

0.0

1.7

—

209.73

—

Marfan's syndrome

0.00

0.21

0.0

1.5

—

154.40

—

Cleft lip and palate

0.00

0.21

0.0

1.6

—

155.30

—

Carcinoma in situ of uteri, other/unspecified

0.00

0.21

0.0

1.2

—

259.40

—

Malignant neoplasm of hypopharynx, including Hilmo

0.00

0.21

0.0

1.3

—

166.60

—

Fall involving playground equipment

0.00

0.21

0.0

4.3

—

116.10

—

Infections specific to the perinatal period

0.00

0.21

0.0

2.9

—

277.20

—

Cleft lip and cleft lip and palate

0.00

0.21

0.0

1.6

—

187.83

—

Superficial injury of ankle and foot

315

1.11

0.21

2.7

2.9

172.71

238.09

e6/l

0.35

306

Adenocarcinoma and Papillary adenocarcinoma of kidney

0.00

0.21

0.0

1.5

—

189.42

—

Diabetes, insulin treatment (Kela reimbursement)

342

1972

1.03

0.21

2.4

2.6

550.95

277.52

e6/l

0.53

330

1921

Epileptic seizures related to alcohol

0.00

0.21

0.0

1.6

—

154.38

—

Degenerative myopia

0.00

0.21

0.0

1.5

—

144.69

—

Benign neoplasm: Bone and articular cartilage, unspecified

0.00

0.21

0.0

1.5

—

210.92

—

Prophylactic surgery

0.00

0.21

0.0

2.2

—

274.23

—

Congenital malformations of eyelid, lacrimal apparatus and orbit

0.00

0.21

0.0

2.7

—

241.08

—

Congenital malformations of eyelid, lacrimal apparatus and orbit, including avohilmo

0.00

0.21

0.0

2.7

—

241.08

—

Mental and behabioural disorders of puerperum, not classified elsewhere, excluding more controls

0.00

0.21

0.0

2.2

—

171.69

—

Pre-eclampsia or eclampsia

543

0.92

0.20

2.0

2.8

112.93

384.94

e6/l

1.32

532

Other osteochondropathies

164

1.16

0.20

5.1

2.8

128.37

136.37

e6/l

0.08

159

Anxious personality disorder

1.25

0.20

1.8

2.7

117.83

162.56

e6/l

—

Inguinal hernia

191

1223

1.04

0.18

2.6

2.7

608.98

328.36

e6/l

0.30

185

1182

Normotensive glaucoma

185

1.14

0.18

2.1

1.9

480.62

119.05

e6/l

0.68

174

Adenomyosis (Endometriosis of uterus)

309

1.10

0.17

1.8

2.4

127.32

525.97

e6/l

0.97

302

L02BX Other hormone antagonists and related agents

138

1.16

0.17

2.6

2.2

77.06

111.75

e6/l

0.86

128

Glaucoma-related operations

110

1.18

0.17

2.1

1.7

136.92

147.32

e6/l

0.07

104

Other aneurysm

110

1.18

0.17

2.4

2.1

113.69

159.37

e6/l

0.61

102

Distal bite

1.19

0.16

5.4

3.1

183.13

166.94

e6/l

—

Gestational [pregnancy-induced] oedema and proteinuria without hypertension

194

0.88

0.16

2.3

2.5

142.59

259.44

e6/l

0.41

187

Benign mammary dysplasia

311

1.09

0.16

2.7

2.3

101.03

545.45

e6/l

1.12

302

Malignant neoplasm of rectum

120

1.17

0.16

1.5

1.9

71.79

141.33

e6/l

1.81

113

Sleep disorders

309

2074

1.03

0.15

2.2

2.7

149.95

305.29

e6/l

2.06

297

2022

Crushed, pushed or stepped on by crowd or human stampede

171

0.88

0.14

2.2

2.9

197.20

160.21

e6/l

0.38

166

Malignant neoplasm of rectum, including Hilmo

150

1.13

0.14

1.4

1.9

77.94

138.63

e6/l

1.56

142

Atherosclerosis, excluding cerebral and coronary sclerosis

113

852

1.04

0.14

2.0

2.3

86.27

426.63

e6/l

1.78

107

819

Obstructed labour due to malposition and malpresentation of fetus

498

1.06

0.14

3.6

2.7

112.49

224.88

e6/l

1.30

491

Mental disorders, not otherwise specified

199

1.11

0.13

2.0

2.9

163.45

281.62

e6/l

0.43

193

Adenocarcinoma, papilloma adenocarcinoma and mucinous carcinomas of rectum

127

0.87

0.12

1.0

2.0

105.00

137.98

e6/l

0.44

120

Mental and behavioural disorders due to psychoactive substance use

197

1757

1.03

0.12

2.5

2.7

164.63

343.01

e6/l

1.74

186

1714

Pedal cyclist injured in noncollision transport accidents

303

0.92

0.12

4.0

2.7

159.11

233.52

e6/l

0.38

295

Benign neoplasm of middle ear and respiratory system

181

1.11

0.12

2.4

2.3

79.10

163.71

e6/l

1.81

173

Dislocation, sprain and strain of joints and ligaments of shoulder girdle

875

1.04

0.12

2.7

209.12

219.65

e6/l

0.05

852

Unspecified abortion

116

0.86

0.12

1.7

3.1

104.20

368.31

e6/l

—

116

Fall on and from stairs and steps

728

1.04

0.12

2.1

2.7

119.42

394.97

e6/l

1.56

702

Medial epicondylitis

1.16

0.11

1.8

2.4

44.73

137.44

e6/l

2.84

Maternal care for known or suspected abnormality of pelvic organs

445

1.05

0.11

2.3

2.7

175.45

228.35

e6/l

0.38

438

Unspecified lump in breast

373

0.94

0.11

2.3

2.4

126.57

384.44

e6/l

0.77

363

Bicipital tendinitis

134

1.12

0.11

3.0

2.4

180.33

133.28

e6/l

0.38

129

Pre-eclampsia or poor fetal growth

786

0.96

0.10

2.4

2.7

116.93

312.12

e6/l

1.40

773

Pre-eclampsia

504

0.95

0.10

2.0

2.8

112.60

274.79

e6/l

1.49

493

Gonarthrosis, primary, with knee surgery

176

1400

0.98

0.09

1.9

2.5

322.34

290.89

e6/l

0.07

167

1355

Supervision of high-risk pregnancy

299

1.05

0.08

1.9

2.5

163.15

253.28

e6/l

0.47

293

Gonarthrosis,primary

284

1737

0.99

0.08

2.3

2.6

501.87

296.78

e6/l

0.31

269

1689

Adenocarcinoma and papilloma adenocarcinoma of rectum

122

0.90

0.07

1.0

1.9

105.00

140.37

e6/l

0.48

115

Personal history of malignant neoplasm

167

1.08

0.06

2.2

2.3

213.67

271.70

e6/l

0.15

162

Other and unspecified injuries of head

167

1.08

0.06

2.3

2.4

124.44

136.85

e6/l

0.14

158

Cholesteatoma of middle ear

104

0.86

0.06

1.9

1.7

78.56

149.55

e6/l

—

Status post-ami

509

1.03

0.05

2.0

2.5

80.00

329.23

e6/l

1.25

489

Arthropod-borne viral fevers and viral haemorrhagic fevers

237

1.06

0.05

3.8

2.6

276.00

148.86

e6/l

0.46

227

Injury of muscle and tendon at hip and thigh level

267

1.05

0.05

2.8

2.7

227.71

234.18

e6/l

0.01

260

Early lumbar disc prolapse operation

267

1.05

0.05

2.5

3.2

988.50

376.82

e6/l

0.34

262

Childhood allergy (age < 16)

277

1.04

0.05

2.4

2.8

176.97

202.29

e6/l

0.40

272

Thyroiditis

171

0.94

0.05

2.1

2.4

105.69

296.18

e6/l

0.64

166

Lichen sclerosus et atrophicus

251

0.96

0.04

2.6

2.4

89.50

237.63

e6/l

0.80

243

Caries of enamel

333

2160

1.01

0.04

2.7

2.6

291.83

303.62

e6/l

0.03

326

2106

Benign lipomatous neoplasm of other sites/unspecified

200

0.95

0.03

1.7

2.1

116.32

155.05

e6/l

0.43

191

Obesity, other/unspecified

952

0.99

0.02

2.4

2.7

296.78

311.65

e6/l

0.04

930

Benign lipomatous neoplasm of skin and subcutaneous tissue of head, face and neck

168

0.95

0.02

1.8

2.6

222.69

137.33

e6/l

0.30

162

Viral haemorrhagic fevers, not elsewhere classified/unspecified

192

1.04

0.02

3.5

2.7

330.85

141.18

e6/l

0.58

186

Insomnia

297

2056

1.00

0.01

2.2

2.7

154.13

299.98

e6/l

1.85

286

2006

Angina pectoris

164

1081

1.01

0.01

2.0

2.7

118.04

342.57

e6/l

1.69

157

1049

Diabetes medication

351

2043

1.00

0.01

2.4

2.6

329.26

269.26

e6/l

0.18

336

1995

Artrosis, including avohilmo

280

1531

1.00

0.00

2.3

2.7

233.50

299.71

e6/l

0.25

266

1497

Foreign body entering into or through eye or natural orifice

188

1.01

0.00

2.4

2.6

137.79

139.92

e6/l

0.02

183

Non-allergic asthma

201

0.99

0.00

1.9

2.6

4244.65

149.78

e6/l

0.56

194

Single delivery by forceps and vacuum extractor

224

0.99

0.00

3.4

2.8

147.70

158.27

e6/l

0.18

219

Sodium-glucose co-transporter 2 (SGLT2) inhibitors

972

1.00

0.00

2.4

2.7

407.87

294.41

e6/l

0.16

946

Long labour

514

1.01

0.00

3.3

2.6

135.11

217.79

e6/l

0.82

505

Glucagon-like peptide-1 (GLP-1) analogues

972

1.00

0.00

2.4

2.7

407.87

294.41

e6/l

0.16

946

Cerebral aneurysm, nonruptured

216

1.02

0.00

2.9

2.4

154.32

123.90

e6/l

0.32

210

Calcific tendinitis of shoulder

153

0.98

0.00

1.6

2.6

396.47

128.19

e6/l

0.48

147

Hydrocephalus

157

1.02

0.00

3.1

2.0

185.62

111.55

e6/l

0.53

150

Endometriosis in cutaneous scar

0.00

0.0

1.4

—

273.88

—

Cholera, including avohilmo

0.00

0.0

1.5

—

182.00

—

Congenital ptosis, including avohilmo

0.00

0.0

2.4

—

207.22

—

Gangrene, not elsewhere classified

0.00

0.0

1.4

—

184.71

—

Klinefelter syndrome, karyotype 47 XXY

0.00

0.0

2.0

—

146.00

—

Other injuries involving multiple body regions, not elsewhere classified

0.00

0.0

2.0

—

174.50

—

Epileptic seizures related to drugs

0.00

0.0

1.7

—

166.00

—

Rifle, shotgun and larger firearm discharge

0.00

0.0

1.8

—

228.50

—

Other and unspecified water transport accidents

0.00

0.0

1.8

—

194.13

—

Congenital hydrocephalus

0.00

0.0

1.4

—

144.00

—

Congenital ptosis

0.00

-0.00

0.0

2.9

—

164.86

—

Ankylosis of joint

0.00

-0.00

0.0

1.5

—

128.67

—

Pedestrian injured in collision with other nonmotor vehicle

0.00

-0.00

0.0

1.6

—

176.80

—

Intentional self-harm by smoke, fire and flames

0.00

-0.00

0.0

1.8

—

169.00

—

Other fibroblastic disorders

0.00

-0.00

0.0

1.4

—

200.60

—

Flexion deformity

0.00

-0.00

0.0

1.8

—

83.80

—

Osteomyelitis of vertebra

0.00

-0.00

0.0

1.6

—

67.60

—

General- and plastic-surgery devices associated with adverse incidents

0.00

-0.00

0.0

2.2

—

224.80

—

Congenital malformation of biliary tract

0.00

-0.00

0.0

1.0

—

354.00

—

Female infertility, uterine origin

0.00

-0.00

0.0

1.3

—

239.89

—

Balanced rearrangements and structural markers, not elsewhere classified

0.00

-0.00

0.0

1.4

—

289.71

—

Cleft hard palate NOS

0.00

-0.00

0.0

1.3

—

154.71

—

General hospital and personal-use devices associated with adverse incidents

0.00

-0.00

0.0

1.4

—

161.20

—

Exposure to electric transmission lines

0.00

-0.00

0.0

2.0

—

138.40

—

Type 1 diabetes, strict definition, subgroup 2

0.00

-0.00

0.0

3.0

—

256.40

—

Mucocutaneous lymph node syndrome [Kawasaki]

0.00

-0.00

0.0

2.7

—

137.29

—

Other specified/unspecified disorders of ear

0.00

-0.00

0.0

2.0

—

179.33

—

Vaginal lichen planus

0.00

-0.00

0.0

1.3

—

159.00

—

Sleepwalking [somnambulism]

0.00

-0.00

0.0

2.0

—

173.43

—

Lipomatosis, not elsewhere classified

0.00

-0.00

0.0

1.4

—

131.43

—

Injury of nerves and lumbar spinal cord at abdomen, lower back and pelvis level

0.00

-0.00

0.0

1.6

—

226.14

—

Eclampsia

0.00

-0.00

0.0

1.5

—

233.33

—

Nightmares

0.00

-0.00

0.0

2.0

—

215.00

—

Pituitary-dependent Cushing's disease

0.00

-0.00

0.0

1.2

—

204.17

—

Injury of blood vessels at hip and thigh level

0.00

-0.00

0.0

1.6

—

130.60

—

Injury of blood vessels at forearm level

0.00

-0.00

0.0

2.0

—

116.00

—

Maternal care for (suspected) damage to fetus from alcohol

0.00

-0.00

0.0

2.0

—

257.56

—

Injury of muscle and tendon at neck level

0.00

-0.00

0.0

1.6

—

166.20

—

Carcinoma in situ of oesophagus

0.00

-0.00

0.0

1.7

—

200.33

—

Dislocations, sprains and strains involving multiple body regions

0.00

-0.00

0.0

2.2

—

220.60

—

Mental and behavioural disorders due to use of volatile solvents

0.00

-0.00

0.0

1.4

—

183.80

—

Slow fetal growth and fetal malnutrition

0.00

-0.00

0.0

5.0

—

227.00

—

Benign neoplasm: Pineal gland

0.00

-0.00

0.0

1.0

—

195.80

—

Bacterial sepsis of newborn

0.00

-0.00

0.0

3.8

—

275.00

—

Other congenital malformations of eye

0.00

-0.00

0.0

2.7

—

329.00

—

Benign neoplasm: Other specified/unspecified intrathoracic organs (+ respiratory system NOS of Icd-9)

0.00

-0.00

0.0

1.9

—

204.86

—

Malignant neoplasm of hypopharynx

0.00

-0.00

0.0

1.4

—

189.71

—

Congenital nasolacrimal duct obstruction or stenosis, including avohilmo

0.00

-0.00

0.0

4.8

—

351.60

—

Sequelae of burns, corrosions and frostbite

0.00

-0.00

0.0

1.8

—

174.00

—

Malignant neoplasm of renal pelvis

0.00

-0.00

0.0

1.4

—

253.60

—

Alzheimer’s disease (undefined)

0.00

-0.00

0.0

1.6

—

100.57

—

Pityriasis lichenoides et varioliformis acuta

0.00

-0.00

0.0

1.6

—

102.40

—

Dengue fever [classical dengue], including avohilmo

0.00

-0.00

0.0

1.7

—

195.33

—

Toxic effect of other noxious substances eaten as food

0.00

-0.00

0.0

1.4

—

116.29

—

Dengue fever [classical dengue]

0.00

-0.00

0.0

1.7

—

195.33

—

Urethral discharge

0.00

-0.00

0.0

2.0

—

138.40

—

Hypospadias with an incomplete glans penis

0.00

-0.00

0.0

1.8

—

98.33

—

Spina bifida

0.00

-0.00

0.0

1.6

—

297.14

—

≡ Risteys

R14

FinnGen R13 + FinRegistry

FinnGen R12 + FinRegistry

FinnGen R11 + FinRegistry

FinnGen R10 + FinRegistry

FinnGen R10

FinnGen R9

FinnGen R8

FinnGen R7

FinnGen R6

FinnGen R5

FinnGen R4

FinnGen R3

CD19 cells [#/volume] in Blood

Coding

Definition

OMOP mapping QC

Cohort

Year of birth distribution

Age at first measurement

Age at last measurement

Age at start of registry

Duration from first to last measurement

Statistics

Number of measurements over the years

Number of measurements per person

Distribution of lab values

Value range per person

LabWAS